Document:

EX-10.3

 Exhibit 10.3 

EXECUTION VERSION 

SECURITY AGREEMENT 

SECURITY AGREEMENT, dated as of May 14, 2015 (this “Agreement”), by and among MILACRON INTERMEDIATE HOLDINGS
INC., a Delaware corporation, MILACRON LLC, a Delaware limited liability company (the “Borrower”), and each of the subsidiaries listed on Annex A hereto (together with the Borrower and Holdings,
collectively, the “Grantors”), in favor of JPMORGAN CHASE BANK, N.A., in its capacity as collateral agent for the Secured Parties pursuant to the Term Loan Agreement (as hereinafter defined) and as pledgee, assignee and
secured party (in such capacities and together with any successors in such capacities, the “Collateral Agent”). 

W I T N E S S E T H: 

WHEREAS, the Borrower, the other Grantors, the Collateral Agent and the lending institutions listed therein have, in connection with
the execution and delivery of this Agreement, entered into that certain Term Loan Agreement, dated as of May 14, 2015 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Term Loan
Agreement”); 
 WHEREAS, pursuant to the Term Loan Agreement, each of the Guarantors has agreed to guarantee to the
Collateral Agent, for the benefit of the Secured Parties, the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of the Secured Obligations (the “Guarantee”); 

WHEREAS, each Grantor will receive substantial benefits from the execution, delivery and performance of the obligations under the Term
Loan Agreement and the other Loan Documents, and each is, therefore, willing to enter into this Agreement; 
 WHEREAS, the Collateral
Agent has been appointed to serve as Collateral Agent under the Term Loan Agreement and, in such capacity, to enter into this Agreement; and 

WHEREAS, it is a condition to (i) the obligations of the Lenders to make the Loans under the Term Loan Agreement and (ii) the
performance of the obligations of the Secured Parties that constitute Secured Obligations that each Grantor execute and deliver the applicable Loan Documents, including this Agreement. 

NOW, THEREFORE, in consideration of the foregoing premises and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, and to induce the Collateral Agent and the Lenders to enter into the Term Loan Agreement, the Grantors hereby agree with the Collateral Agent, for the benefit of the Secured Parties, as follows: 

1. Defined Terms. 
 (a)
(i) Unless otherwise defined herein, terms defined in the Term Loan Agreement and used herein (including terms used in the preamble and the recitals) shall have the meanings given to them in the Term Loan Agreement and (ii) all terms
defined in the Uniform Commercial Code from time to time in effect in the State of New York (the “NY UCC”) and not defined herein or in the Term Loan Agreement shall have the meanings specified therein (and if defined in more than
one article of the NY UCC, shall have the meaning specified in Article 9 thereof). 
 (b) The rules of construction and other interpretive
provisions specified in the Term Loan Agreement shall apply to this Agreement, including terms defined in the preamble and recitals hereto. 

 (c) The following terms shall have the following meanings: 

“After-Acquired Intellectual Property Collateral” shall have the meaning assigned to such term in Section 4.1(b). 

“Agreement” shall have the meaning assigned to such term in the preamble hereto. 

“Chattel Paper” shall mean all “chattel paper” as such term is defined in Article 9 of the NY UCC. 

“Collateral” shall have the meaning assigned to such term in Section 2. 

“Collateral Agent” shall have the meaning assigned to such term in the recitals hereto. 

“Commercial Tort Claims” shall mean all “commercial tort claims,” as such term is defined in Article 9 of the NY
UCC. 
 “Commodity Account” shall mean all “commodity accounts,” as such term is defined in Article 8 of the NY
UCC. 
 “Copyrights” shall mean all (a) copyrights in any work subject to the copyright laws of the United States, or
of any other country or any group of countries, whether registered or unregistered and whether published or unpublished, including copyrights in computer software and the content thereof, and internet web sites, (b) registrations, recordings
and applications for registration of any such copyright in the United States or any other country, including registrations, recordings, supplemental registrations and pending applications for registration in the United States Copyright Office, and
(c) rights to obtain all renewals thereof. 
 “Deposit Accounts” shall mean all “deposit accounts,” as such
term is defined in Article 9 of the NY UCC. 
 “Deposit Account Control Agreement” shall mean an agreement among the
Collateral Agent, any Grantor and the relevant depository bank, in form and substance reasonably satisfactory to the Collateral Agent, granting control of such Grantor’s Deposit Accounts maintained at such depository bank in accordance with
Section 9-104 of the Uniform Commercial Code in effect in the jurisdiction of such depository bank. 
 “Documents”
shall mean all “documents,” as such term is defined in Article 9 of the NY UCC. 
 “Equipment” shall mean all
“equipment,” as such term is defined in Article 9 of the NY UCC. 
 “Exclusive IP Agreements” shall have the
meaning assigned to such term in Section 3.2(a). 
 “Event of Default” shall mean an “Event of Default” under and
as defined in the Term Loan Agreement. 
 “Excluded Accounts” means the Deposit Accounts, Securities Accounts and Commodity
Accounts (i) which are used for the sole purpose of making payroll and withholding tax payments related 

  
 -2- 

 
thereto and other employee wage and benefit payments and accrued and unpaid employee compensation (including salaries, wages, benefits and expense reimbursements), (ii) which are used for
the sole purpose of paying taxes, including sales taxes, (iii) which are used for the sole purpose of holding the proceeds of Term Priority Collateral pending reinvestment by the Grantors or application against the Term Loan Debt and/or the
related Guarantees to the extent permitted by the Term Loan Agreement, (iv) which are used exclusively as escrow accounts or as fiduciary or trust accounts or (v) which, individually or in the aggregate, have an average daily balance for
any fiscal month of less than $5,000,000. 
 “Excluded Assets” shall mean means the collective reference to: (a) motor
vehicles and other assets subject to certificates of title, letter of credit rights (except to the extent perfection can be accomplished through the filing of UCC-1 financing statements) and Commercial Tort Claims with a value of less than
$5,000,000; (b) assets to the extent pledges and security interests in such assets are prohibited by Applicable Law, rule or regulation (including the requirement to obtain consent of any governmental authority); (c) assets to the extent a
security interest in such assets would result in adverse tax consequences (including, without limitation, as a result of the operation of Section 956 of the Code or any similar law or regulation in any applicable jurisdiction) or adverse
regulatory consequences, in each case as reasonably determined by the Borrower and notified to the Collateral Agent in writing; (d) any lease, license or other agreement or any property subject to a Purchase Money Lien or similar arrangement to
the extent that a grant of a security interest therein would violate or invalidate such lease, license or agreement or purchase money arrangement or create a right of termination in favor of, or require the consent of, any other party thereto after
giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code, other than Proceeds and receivables thereof, the assignment of which is expressly deemed effective under the Uniform Commercial Code notwithstanding such
prohibition; (e) those assets as to which the cost or burden of obtaining such a security interest or perfection thereof are excessive in relation to the benefit to the Secured Parties of the security to be afforded thereby (as agreed to in
writing by the Borrower and the Collateral Agent); (f) any governmental licenses or state or local franchises, charters and authorizations, to the extent security interests in such licenses, franchises, charters or authorizations are prohibited
or restricted thereby after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code; (g) any leasehold real property; (h) any foreign Intellectual Property; (i) U.S. “intent-to-use”
trademark or service mark applications to the extent that a verified statement of use or an amendment to allege use has not been filed with and accepted by the United States Patent and Trademark Office with respect thereto; (j) Excluded
Accounts described in clause (i), (ii) and (iv) of the definition of Excluded Accounts and (k) Excluded Capital Stock; provided that “Excluded Assets” shall not include any asset or property that any Loan Party has
granted a Lien on or security interest in to secure the obligations under the ABL Facility. 
 “Excluded Capital Stock”
means, (a) in the case of any pledge of Equity Interests of any Foreign Subsidiary or of any Domestic Subsidiary, substantially all of the assets which consist of the Equity Interests of one or more Foreign Subsidiaries, any Equity Interests
that are voting Equity Interests of such Subsidiary in excess of 65% of the outstanding voting Equity Interests; (b) the Equity Interests of any Subsidiary of a Foreign Subsidiary; (c) in the case of Equity Interests in any partnership,
joint venture or subsidiary that is not a Wholly-Owned Subsidiary, any Equity Interests in such Person to the extent any organizational document or contractual obligation prohibits such a pledge; (d) any Equity Interests the pledge of which
would require the consent, approval, license or authorization of any governmental authority or is otherwise not permitted by Applicable Law; (e) any Equity Interests that constitutes Margin Stock (as defined in Regulation U of the Board of
Governors of the Federal Reserve System of the United States of America); and (f) any Equity Interests in (i) any captive insurance Subsidiary, (ii) any not-for-profit Subsidiary and (iii) any Subsidiary that is a special purpose
vehicle for securitization financings permitted by the Term Loan Agreement and (iv) any Unrestricted Subsidiary. 

“Fixtures” shall mean all “fixtures,” as such term is defined in Article 9 of the NY UCC. 

  
 -3- 

 “General Intangibles” shall mean all “general intangibles” as such
term is defined in Article 9 of the NY UCC. 
 “Guarantee” shall have the meaning assigned to such term in the recitals
hereto. 
 “Grantor” shall have the meaning assigned to such term in the preamble hereto and shall include each Person that
becomes a party hereto pursuant to Section 7.13. 
 “Intellectual Property” shall mean any and all intellectual and
similar intangible property, including Trade Secrets, Copyrights, Patents, Trademarks and the IP Agreements and all Proceeds thereof. 

“Intellectual Property Collateral” shall mean the Collateral constituting Intellectual Property, including the Intellectual
Property set forth in Schedules 1 and 2 (and in any supplement thereto received pursuant to this Agreement) hereto. 
 “Intellectual
Property Security Agreement” shall have the meaning assigned to such term in Section 4.3(e). 
 “Instruments”
shall mean all “instruments,” as such term is defined in Article 9 of the NY UCC. 
 “Inventory” shall mean all
“inventory,” as such term is defined in Article 9 of the NY UCC. 
 “Investment Property” shall mean all
“investment property,” as such term is defined in Article 9 of the NY UCC. 
 “IP Agreements” shall mean any and
all agreements, permits, consents, orders and franchises, now or hereafter in effect, relating to the license, sublicense, development, use, manufacture, distribution, sale or disclosure of any Copyrights, Patents, Trademarks, or Trade Secrets to
which any Grantor, now or hereafter, is a party. 
 “NY UCC” shall have the meaning assigned to such term in
Section 1(a)(ii). 
 “Patents” shall mean (a) all patents of the United States or the equivalent thereof in any
other country or group of countries, all registrations, recordings and extensions thereof, and all applications for patent of the United States or the equivalent thereof in any other country, including patent registrations, statutory invention
registrations, utility models, recordings and pending applications in the United States Patent and Trademark Office or any similar offices in any other country, and (b) all provisionals, reissues, reexaminations, continuations, divisions,
continuations-in-part, renewals or extensions thereof, and in the case of (a) and (b), all the inventions or discoveries disclosed or claimed therein and all improvements thereto, including the right to make, use and/or sell the inventions or
discoveries disclosed or claimed therein. 
 “Proceeds” shall mean all “proceeds” as such term is defined in
Article 9 of the NY UCC and, in any event, shall include with respect to any Grantor, any consideration received from the sale, exchange, license, lease or other disposition of any asset or property that constitutes Collateral, any value received as
a consequence of the possession of any Collateral and any payment received from any insurer or other person or entity as a result of the destruction, loss, theft, damage or other involuntary conversion of whatever nature of any asset or property
that constitutes Collateral, and shall include (a) all cash and 

  
 -4- 

 
negotiable instruments received by or held on behalf of the Collateral Agent, (b) any claim of any Grantor against any third party for (and the right to sue and recover for and the rights to
damages or profits due or accrued arising out of or in connection with) (i) past, present or future infringement or dilution, where applicable, of any Patent, Trademark, Copyright or Trade Secret, now or hereafter owned by any Grantor, or
licensed under an IP Agreement or injury to the goodwill associated with or symbolized by any Trademark now or hereafter owned by any Grantor, and (ii) past, present or future breach of any IP Agreement and (c) any and all other amounts
from time to time paid or payable under or in connection with any of the Collateral. 
 “Registered Intellectual Property”
shall have the meaning set forth in Section 3.2(a). 
 “Revolving Agent” shall have the meaning assigned to such term
in the Intercreditor Agreement. 
 “Revolving Liens” shall mean Liens securing the Revolving Obligations (as such term is
defined in the Intercreditor Agreement). 
 “Revolving Loan Documents” shall have the meaning assigned to such term in the
Inter-creditor Agreement. 
 “Revolving Priority Collateral” shall have the meaning assigned to such term in the
Inter-creditor Agreement. 
 “Security Interest” shall have the meaning assigned to such term in Section 2(a). 

“Securities Account” shall mean any “securities account,” as such term is defined in Article 8 of the NY UCC. 

“Trademarks” shall mean (a) all trademarks, service marks, domain names, trade names, corporate names, company names,
business names, fictitious business names, domain names, trade styles, trade dress, logos, slogans, other source or business identifiers, now existing or hereafter adopted or acquired, whether registered or unregistered, and all registrations,
recordings and applications for registration filed in connection with the foregoing, including registrations, recordings and applications for registration in the United States Patent and Trademark Office or any similar offices in any State of the
United States or any other country, group of countries or any political subdivision thereof, and all common-law rights related thereto, (b) all goodwill associated therewith or symbolized thereby and (c) all extensions or renewals thereof.

 “Trade Secrets” shall mean all confidential and proprietary information, including knowhow, trade secrets, technology,
manufacturing and production processes and techniques, inventions, research and development information, databases and data, including, without limitation, technical data, financial, marketing and business data, pricing and cost information,
business and marketing plans and customer and supplier lists and information. 
 2. Grant of Security Interest. 

(a) Each Grantor hereby assigns, pledges, mortgages and hypothecates to the Collateral Agent, its successors and permitted assigns, for the
benefit of the Secured Parties, and hereby grants to the Collateral Agent, its successors and permitted assigns, for the benefit of the Secured Parties, a security interest in and continuing Lien on (the “Security Interest”) all of
such Grantor’s right, title and interest in (subject only to Permitted Liens) to all of the following assets and property now owned or 

  
 -5- 

 
anytime hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the “Collateral”)
as collateral security for the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of the Secured Obligations: 

(i) all Accounts; 

(ii) all cash; 

(iii) all Chattel Paper; 

(iv) all Commercial Tort Claims described in Schedule 3 (and on any supplement thereto received pursuant to this
Agreement); 
 (v) all Deposit Accounts; 

(vi) all Documents; 

(vii) all Equipment; 

(viii) all Fixtures; 

(ix) all General Intangibles; 

(x) all Goods; 

(xi) all Instruments; 

(xii) all Intellectual Property; 

(xiii) all Inventory; 

(xiv) all Investment Property; 

(xv) Letter of Credit Rights; 

(xvi) all Money; 

(xvii) all Securities Accounts and Commodity Accounts; 

(xviii) all books and records pertaining to the Collateral; 

(xix) all Supporting Obligations; and 

(xx) to the extent not covered by clauses (i) through (xix) of this sentence, all other personal property of such
Grantor, whether tangible or intangible, and all Proceeds and products of each of the foregoing and all accessions to, substitutions and replacements for, and rents, profits and products of, each of the foregoing, any and all Proceeds of any
insurance, indemnity, warranty or guaranty payable to such Grantor from time to time with respect to any of the foregoing; 

  
 -6- 

 (b) each Grantor hereby grants to the Revolving Agent for the benefit of the Term Loan
Claimholders (as defined in the Intercreditor Agreement and including, without limitation, the Secured Parties) a security interest in all rights of such Grantors under the Deposit Accounts; 

provided, however, that notwithstanding any other provision of this Agreement or the other Loan Documents (a) the Collateral (including the
definition thereof and any component definition thereof) shall not include any Excluded Assets; and (b) no Grantor shall be required to perfect the Security Interests in the Collateral created hereby by any means other than (i) filings
pursuant to the Uniform Commercial Code, (ii) filings with United States’ governmental offices with respect to Registered Intellectual Property, (iii) in the case of Collateral that constitutes Pledged Debt (as defined in the Pledge
Agreement) with a value in excess, individually, of $5,000,000 or Pledged Shares (as defined in the Pledge Agreement), in each case, to the extent included in the Collateral, delivery to the Collateral Agent to be held in its possession,
(iv) perfection by Control in Deposit Accounts to the extent required hereunder and (v) any other actions expressly relating to perfection on the Collateral required by the Term Loan Agreement and other applicable Security Documents.
Furthermore, (a) no Grantor shall be required to complete any filings or take any other action with respect to the grant, perfection or enforcement of the Security Interests in any jurisdiction outside of the United States and (b) in no
event shall control agreements or control or similar arrangements be required with respect to Deposit Accounts, Securities Accounts or Commodity Accounts or other assets or property requiring perfection through control except as expressly required
hereunder or under the Pledge Agreement. 
 (c) Each Grantor hereby irrevocably authorizes the Collateral Agent at any time and from time to
time to file in any relevant jurisdiction any financing statements (including fixture filings) with respect to the Collateral or any part thereof and amendments thereto and continuations thereof that contain the information required by Article 9 of
the Uniform Commercial Code of each applicable jurisdiction for the filing of any financing statement or amendment or continuation, including whether such Grantor is an organization, the type of organization and any organizational identification
number issued to such Grantor. Such financing statements may describe the Collateral in the same manner as described herein or may contain an indication or description of collateral that describes such property in any other manner such as “all
assets” or “all personal property, whether now owned or hereafter acquired” of such Grantor or words of similar effect as being of an equal or lesser scope or with greater detail and in the case of a financing statement filed as a
fixture filing or covering the Collateral constituting minerals or the like to be extracted or timber to be cut, a sufficient description of the real property to which such Collateral relates. Each Grantor agrees to provide such information to the
Collateral Agent promptly upon reasonable request. 
 Each Grantor also ratifies any authorization previously given in writing to the
Collateral Agent to file in any relevant jurisdiction any initial financing statements or amendments thereto or continuations thereof if filed prior to the date hereof. 

The Collateral Agent is further authorized to file with the United States Patent and Trademark Office or United States Copyright Office (or
any successor office) for the purpose of perfecting, continuing or providing notice of the Security Interests granted by each Grantor hereunder, and naming any Grantor or the Grantors as debtors and the Collateral Agent as secured party. 

The Security Interest secures the payment of all the Secured Obligations. Without limiting the generality of the foregoing, the Security
Interest secures the payment of all amounts that constitute part of the Secured Obligations and would be owed to the Collateral Agent or the Secured Parties but for the fact that they are unenforceable or not allowable due to the existence of a
bankruptcy, reorganization or similar proceeding involving any Grantor. 

  
 -7- 

 The Security Interests created hereby are granted as security only and shall not subject the
Collateral Agent or any other Secured Party to, or in any way alter or modify, any obligation or liability of any Grantor with respect to or arising out of the Collateral. 

Notwithstanding anything to the contrary contained in this Agreement, the Liens granted above, and the relative priority thereof, shall be set
forth in, and subject to the terms and conditions of, the Intercreditor Agreement. 
 3. Representations And Warranties. 

Each Grantor hereby represents and warrants to the Collateral Agent, for the benefit of the Secured Parties, that: 

3.1. Title; No Other Liens. Except for (a) the Security Interest granted to the Collateral Agent, for the benefit
of the Secured Parties, pursuant to this Agreement, (b) the Liens securing the Revolving Obligations, and (c) other Permitted Liens, such Grantor owns each item of the Collateral free and clear of any and all Liens. None of the Grantors
has filed or consented to the filing of any (x) financing statement or analogous document under the Uniform Commercial Code or any other Applicable Laws covering any Collateral, or (y) assignment for security in which any Grantor assigns
any Collateral or any security agreement or similar instrument covering any Collateral with the United States Patent and Trademark Office or the United States Copyright Office, which security agreement, financing statement or similar instrument or
assignment is still in effect, except in the case of each of clauses (x) and (y) above, such as have been filed in favor of the Collateral Agent pursuant to this Agreement and the other Loan Documents, or are filed in respect of Revolving
Liens or other Permitted Liens. 
 3.2. Intellectual Property. 

(a) The Intellectual Property Collateral set forth on (i) Schedule 1 hereto is a true and correct list of all United States patents,
patent applications, trademark registrations and applications for registration, copyright registrations and applications for registration, and domain names (collectively, the “Registered Intellectual Property”), in each case, owned
by a Grantor in its name as of the date hereof, and indicating for each such item, as applicable, the application and/or registration number, date and jurisdiction of filing and/or issuance, the identity of the current applicant or registered owner,
and (ii) Schedule 2 hereto is a true and correct list of all IP Agreements (other than non-exclusive license agreements or licenses of commercially available off-the-shelf software), in which a Grantor is, as of the date hereof, the exclusive
licensee of any United States patent, patent application, trademark registration or application for registration, copyright registration or application for registration (collectively, the “Exclusive IP Agreements”). 

Except as would not reasonably be expected to result in a Material Adverse Effect (in each case of clauses (b) through (d) below):

 (b) The Registered Intellectual Property is subsisting and has not been adjudged invalid or unenforceable in whole or in part, and to such
Grantor’s knowledge is valid and enforceable and has not been abandoned. Such Grantor is not aware of any uses of any item of Registered Intellectual Property that could be expected to lead to such item becoming invalid or unenforceable. 

(c) To such Grantor’s knowledge, no Person is engaging in any activity that infringes, misappropriates, dilutes, misuses or otherwise
violates the Registered Intellectual Property or the Grantor’s rights in or use thereof. 

  
 -8- 

 (d) No breach or default of any IP Agreement shall be caused by any of the following, and none of
the following shall limit or impair the ownership, use, validity or enforceability of, or any rights of such Grantor in, any Registered Intellectual Property: (i) the consummation of the transactions contemplated by any Loan Document or
(ii) any holding, decision, judgment or order rendered by any Governmental Authority. 
 3.3. Perfected Security
Interests. 
 (a) Subject to the limitations set forth in this Agreement, the Security Interests granted pursuant to this Agreement
(i) will constitute valid perfected security interests in the Collateral in favor of the Collateral Agent, for the benefit of the Secured Parties, as collateral security for the Secured Obligations, upon (A) in the case of Collateral in
which a security interest may be perfected by filing a financing statement under the Uniform Commercial Code, the completion of the filing, registration and recording of financing statements naming each Grantor as “debtor” and the
Collateral Agent as “secured party” and describing the Collateral in the applicable filing offices, (B) in the case of Collateral that constitutes Pledged Debt (as defined in the Pledge Agreement) with a value in excess, individually,
of $5,000,000 or Pledged Shares (as defined in the Pledge Agreement), in each case, the delivery thereof with transfer powers executed in blank to the Collateral Agent, (C) in the case of Deposit Accounts, the execution of Deposit Account
Control Agreements, and/or (D) in the case of Registered Intellectual Property in which a security interest may be perfected by making such a filing, the completion of the filing, registration and recording of fully executed agreements in the
form of the Intellectual Property Security Agreement set forth in Exhibit 2 hereto (x) in the United States Patent and Trademark Office and (y) in the United States Copyright Office, and (ii) subject to the terms of the Intercreditor
Agreement, are prior to all other Liens on the Collateral other than Permitted Liens having priority over the Collateral Agent’s Lien by operation of law or otherwise as permitted under the Term Loan Agreement (including Revolving Liens). It
being understood and agreed that the representation and warranty set forth in this Section 3.3(a) shall be qualified to the extent that any action required to grant, perfect or enforce a security interest in the applicable Collateral is not
required under the terms of the Loan Documents. 
 (b) It is understood and agreed that the Security Interests created hereby shall not
prevent the Grantors from using the Collateral in the ordinary course of their respective businesses. 
 4. Covenants. 

Each Grantor hereby covenants and agrees with the Collateral Agent, for the benefit of the Secured Parties, that, from and after the date of
this Agreement until the Termination Date: 
 4.1. Maintenance of Perfected Security Interest; Further Documentation.

 (a) Such Grantor shall maintain the Security Interests created hereby as perfected security interests (subject to any Permitted Lien,
Revolving Liens and the terms of the Intercreditor Agreement) and shall take commercially reasonable actions to defend the Security Interests created hereby and the priority thereof against the claims and demands of all Persons whomsoever, other
than holders of Permitted Liens. 
 (b) Each Grantor agrees that should it, after the date hereof, obtain an ownership interest in any
Registered Intellectual Property that would, had it been owned on the date hereof, be considered a part of the Intellectual Property Collateral or should it become a party to any IP Agreement that would, had such Grantor been a party to it on the
date hereof, be considered an Exclusive IP Agreement (“After-Acquired Intellectual Property Collateral”), (i) such After-Acquired Intellectual Property Collateral shall automatically become part of the Intellectual Property
Collateral, subject to the terms and conditions 

  
 -9- 

 
of this Agreement with respect thereto, and (ii) and such Grantor shall promptly, and in any event prior to or concurrently with the next succeeding reports to be delivered pursuant to
Section 5.2(a) and (b) of the Term Loan Agreement, notify the Collateral Agent of the ownership of such After-Acquired Intellectual Property Collateral and, upon the reasonable request of the Collateral Agent, promptly execute and deliver
to the Collateral Agent agreements substantially in the form of Exhibit 2 hereto covering such After-Acquired Intellectual Property Collateral to be recorded with the United States Patent and Trademark Office, the United States Copyright Office and
any other Governmental Authorities located in the United States necessary to perfect the Security Interest hereunder in any such After-Acquired Intellectual Property Collateral which is Registered Intellectual Property. 

(c) Subject to clause (d) below and Section 2, each Grantor agrees that at any time and from time to time, at the expense of such
Grantor, it will execute any and all further documents, financing statements, agreements and instruments, and take all such further actions (including the filing and recording of financing statements and other documents), which may be required under
any Applicable Law, or which the Collateral Agent may reasonably request, in order (x) to grant, preserve and perfect the validity and priority of the Security Interests created hereby or (y) to enable the Collateral Agent to exercise and
enforce its rights and remedies hereunder, including the filing of any financing or continuation statements under the Uniform Commercial Code with respect to the security interests created hereby, all at the expense of such Grantor. Without limiting
the generality of the foregoing, such Grantor shall comply with Section 5.10 of the Term Loan Agreement. 
 (d) Notwithstanding
anything in this Section 4.1 to the contrary, (i) with respect to any assets acquired by such Grantor after the date hereof that constitute Collateral or (ii) with respect to any Person that, subsequent to the date hereof, becomes a
Subsidiary of the Borrower that is required by the Term Loan Agreement to become a party hereto, the relevant Grantor after the acquisition or creation thereof shall promptly take all actions required by the Term Loan Agreement or this
Section 4.1. 
 4.2. Changes in Locations, Name, etc. Each Grantor shall furnish to the Collateral Agent prompt
written notice of any change in such Grantor’s (i) legal name, (ii) jurisdiction of organization or formation, (iii) identity or corporate structure or (iv) federal taxpayer identification number. The Grantors shall, within
the applicable statutory periods, make all filings under the Uniform Commercial Code or otherwise that are required in order for the Collateral Agent to continue at all times following such change to have a valid, legal and perfected security
interest in all the Collateral and take all actions necessary to ensure that the Liens created under the Security Documents continue to be valid and perfected at all times following such change to the same extent as they were valid and perfected
immediately prior to such change. 
 4.3. Intellectual Property. 

(a) With respect to each material item of Intellectual Property Collateral owned by each Grantor that is Registered Intellectual Property,
each Grantor agrees to take, at its expense, steps consistent with such Grantor’s reasonable business judgment, including, as applicable, in the United States Patent and Trademark Office, the United States Copyright Office and any other
Governmental Authority located in the United States, to (i) maintain the validity and enforceability of such Intellectual Property Collateral and maintain such Intellectual Property Collateral in full force and effect, and (ii) pursue the
registration and maintenance of each Patent, Trademark, or Copyright registration or application for registration, now or hereafter included in such Intellectual Property Collateral of such Grantor. 

(b) Except to the extent permitted by Section 4.3(c) below, or to the extent that failure to act could not reasonable be expected to
result in a Material Adverse Effect, each Grantor shall 

  
 -10- 

 
(and shall cause all its licensees to), in such Grantor’s reasonable business judgment (i) (1) continue to use each Trademark included in the Intellectual Property Collateral in
order to maintain such Trademark in full force and effect with respect to each class of goods for which such Trademark is currently used, free from any claim of abandonment for non-use, (2) maintain at least the same standards of quality of
products and services offered under such Trademark as are currently maintained, (3) use such Trademark with the appropriate notice of registration and all other notices and legends required by Applicable Law, (4) not adopt or use any other
Trademark that is confusingly similar or a colorable imitation of such Trademark unless the Collateral Agent shall obtain a perfected security interest in such other Trademark pursuant to this Agreement and (ii) not do any act or omit to do any
act whereby (w) such Trademark (or any goodwill associated therewith) may become destroyed, invalidated, impaired or harmed in any way, (x) any Patent included in the Intellectual Property Collateral may become forfeited, misused,
unenforceable, abandoned or dedicated to the public or (y) any portion of the Copyrights included in the Intellectual Property Collateral may become invalidated, otherwise impaired or fall into the public domain. 

(c) Notwithstanding the foregoing or elsewhere in this Agreement, nothing in this Agreement shall prevent any Grantor from discontinuing use
or maintenance of or otherwise abandoning any owned Intellectual Property Collateral, or from failing to take action to enforce license agreements or pursue actions against infringers, if such Grantor determines in its reasonable business judgment
that abandonment, discontinuance, or failure to take action in respect of such Intellectual Property Collateral is desirable in the conduct of such Grantor’s business. 

(d) In the event that any Grantor becomes aware after the date hereof that any item of its material Intellectual Property Collateral is being
infringed or misappropriated by a third party in any way that would reasonably be expected to have a Material Adverse Effect, such Grantor shall promptly notify the Collateral Agent and take such actions, at its expense, as such Grantor deems
reasonable and appropriate under the circumstances to protect or enforce such Intellectual Property Collateral, including, if such Grantor deems it necessary, suing for infringement or misappropriation and for an injunction against such infringement
or misappropriation. 
 (e) With respect to its Registered Intellectual Property owned by such Grantor in its own name on the date hereof,
each Grantor agrees to execute or otherwise authenticate an agreement, in substantially the form set forth in Exhibit 2 hereto (an “Intellectual Property Security Agreement”), for recording the Security Interest granted hereunder to
the Collateral Agent in such Registered Intellectual Property with the United States Patent and Trademark Office, the United States Copyright Office and any other Governmental Authorities located in the United States necessary to perfect the
Security Interest hereunder in such Registered Intellectual Property. 
 4.4. Commercial Tort Claims. As of the date
hereof, each Grantor hereby represents and warrants that it holds no Commercial Tort Claims with damages in excess of $5,000,000 other than those listed in Schedule 3. If any Grantor shall at any time hold or acquire a Commercial Tort Claim,
such Grantor shall promptly, and in any event prior to or concurrently with the next succeeding reports to be delivered pursuant to Section 5.2(a) and (b) of the Term Loan Agreement, notify the Collateral Agent in writing signed by such
Grantor of the brief details thereof and grant to the Collateral Agent in such writing a security interest therein and in the Proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably
satisfactory to the Collateral Agent. The requirement in the preceding sentence shall not apply to the extent that the amount of such Commercial Tort Claim does not exceed $5,000,000 in the aggregate for all Grantors. 

4.5. Deposit Accounts. The Grantors shall promptly enter into Deposit Account Control Agreements with respect to each
Deposit Account maintained by them other than any Excluded 

  
 -11- 

 
Account, provided that the requirement of this Section 4.5 shall be deemed satisfied for so long as the Revolving Agent is acting as agent for the benefit of the Collateral Agent and the
Secured Parties pursuant to the Intercreditor Agreement with respect to each control agreement the Revolving Agent is a party to and so long as the ABL Facility is outstanding subject to any requirements set forth in the ABL Facility with respect to
the timing of delivery of such control agreements to the Revolving Agent. 
 5. Remedial Provisions. 

5.1. Proceeds to be Turned Over To Collateral Agent. If an Event of Default shall occur and be continuing and the
Collateral Agent so requires by notice in writing to the relevant Grantor (it being understood that the exercise of remedies by the Secured Parties in connection with an Event of Default under Section 7.1(a) or (h) of the Term Loan
Agreement shall be deemed to constitute a request by the Collateral Agent for the purposes of this sentence and in such circumstances, no such written notice shall be required), all Proceeds of Collateral received by any Grantor consisting of cash,
checks and other near-cash items shall be held by such Grantor in trust for the Collateral Agent and the other Secured Parties, segregated from other funds of such Grantor, and shall, forthwith upon receipt by such Grantor, be turned over to the
Collateral Agent in the exact form received by such Grantor (duly endorsed by such Grantor to the Collateral Agent, if required). All Proceeds received by the Collateral Agent hereunder shall be held by the Collateral Agent in a Collateral Account
maintained under its sole dominion and control and on terms and conditions reasonably satisfactory to the Collateral Agent. All Proceeds while held by the Collateral Agent in a Collateral Account (or by such Grantor in trust for the Collateral Agent
and the other Secured Parties) shall continue to be held as collateral security for all the Secured Obligations and shall not constitute payment thereof until applied as provided in Section 5.2 hereof. 

5.2. Application of Proceeds. 

(a) Subject to the terms of the Intercreditor Agreement, upon the occurrence and continuance of an Event of Default, all proceeds received by
the Collateral Agent in respect of any sale of, collection from or other realization upon all or any part of the Collateral shall be applied as provided in Section 7.3 of the Term Loan Agreement. 

(b) Upon any sale of the Collateral by the Collateral Agent (including pursuant to a power of sale granted by statute or under a judicial
proceeding), the receipt of the Collateral Agent or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Collateral so sold and such purchaser or purchasers shall not be obligated to see to the
application of any part of the purchase money paid over to the Collateral Agent or such officer or be answerable in any way for the misapplication thereof. 

5.3. Code and Other Remedies. If an Event of Default shall occur and be continuing and subject to the terms of the
Intercreditor Agreement, the Collateral Agent may exercise in respect of the Collateral, in addition to all other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a secured party upon default under
the NY UCC or any other Applicable Law or in equity and also may without demand of performance or other demand, presentment, protest, advertisement or notice of any kind except as specified below, sell the Collateral or any part thereof in one or
more parcels at public or private sale, at any exchange broker’s board or at any of the Collateral Agent’s offices or elsewhere, for cash, on credit or for future delivery, at such price or prices and upon such other terms as are
commercially reasonable irrespective of the impact of any such sales on the market price of the Collateral. The Collateral Agent shall be authorized at any such sale (if it deems it advisable to do so) to restrict the prospective bidders or
purchasers of Collateral to Persons who will represent and agree that they are purchasing the Collateral for their own account for 

  
 -12- 

 
investment and not with a view to the distribution or sale thereof, and, upon consummation of any such sale, the Collateral Agent shall have the right to assign, transfer and deliver to the
purchaser or purchasers thereof the Collateral so sold. Each purchaser at any such sale shall hold the property sold absolutely free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by law)
all rights of redemption, stay and/or appraisal that it now has or may at any time in the future have under any rule of law or statute now existing or hereafter enacted. The Collateral Agent or any Secured Party shall have the right upon any such
public sale, and, to the extent permitted by law, upon any such private sale, to purchase the whole or any part of the Collateral so sold, and the Collateral Agent or such Secured Party may subject to the satisfaction of the Secured Obligations in
accordance with the priorities set forth in Section 5.2(a) hereof, pay the purchase price by crediting the amount thereof against the Secured Obligations. Each Grantor agrees that, to the extent notice of sale shall be required by law, at least
ten days’ notice to such Grantor of the time and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Collateral Agent shall not be obligated to make any sale of
Collateral regardless of notice of sale having been given. The Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the
time and place to which it was so adjourned. To the extent permitted by law, each Grantor hereby waives any claim against the Collateral Agent arising by reason of the fact that the price at which any Collateral may have been sold at such a private
sale was less than the price that might have been obtained at a public sale, even if the Collateral Agent accepts the first offer received and does not offer such Collateral to more than one offeree. Each Grantor further agrees, at the Collateral
Agent’s request, to assemble the Collateral and make it available to the Collateral Agent at places which the Collateral Agent shall reasonably select, whether at such Grantor’s premises or elsewhere. The Collateral Agent shall apply the
net proceeds of any action taken by it pursuant to this Section 5.3 in accordance with the provisions of Section 5.2 hereof. As an alternative to exercising the power of sale herein conferred upon it, the Collateral Agent may proceed by a
suit or suits at law or in equity to foreclose this Agreement and to sell the Collateral or any portion thereof pursuant to a judgment or decree of a court or courts having competent jurisdiction or pursuant to a proceeding by a court-appointed
receiver. Any sale pursuant to the provisions of this Section 5.3 shall be deemed to conform to the commercially reasonable standards as provided in Section 9-610(b) of the NY UCC or its equivalent in other jurisdictions. 

5.4. Deficiency. Each Grantor shall remain liable for any deficiency if the proceeds of any sale or other disposition of
the Collateral are insufficient to pay the Secured Obligations and the fees and disbursements of any attorneys employed by the Collateral Agent or any Secured Party to collect such deficiency. 

5.5. Amendments, etc. with Respect to the Secured Obligations; Waiver of Rights. Each Grantor shall remain obligated
hereunder notwithstanding that, without any reservation of rights against any Grantor and without notice to or further assent by any Grantor, (a) any demand for payment of any of the Secured Obligations made by the Collateral Agent or any other
Secured Party may be rescinded by such party and any of the Secured Obligations continued, (b) the Secured Obligations, or the liability of any other party upon or for any part thereof, or any collateral security or guarantee therefor or right
of offset with respect thereto, may, from time to time, in whole or in part, be renewed, extended, amended, modified, accelerated, compromised, waived, surrendered or released by the Collateral Agent or any other Secured Party, (c) the Loan
Documents and any other documents executed and delivered in connection therewith may be amended, modified, supplemented or terminated, in whole or in part, in accordance with the terms of the applicable Loan Document, and (d) any collateral
security, guarantee or right of offset at any time held by the Collateral Agent or any other Secured Party for the payment of the Secured Obligations may be sold, exchanged, waived, surrendered or released. Neither the Collateral Agent nor any other
Secured Party shall have any 

  
 -13- 

 
obligation to protect, perfect or insure any Lien at any time held by it as security for the Secured Obligations or for this Agreement or any property subject thereto. When making any demand
hereunder against any Grantor, the Collateral Agent or any other Secured Party, may, but shall be under no obligation to, make a similar demand on the Borrower or any other Grantor, and any failure by the Collateral Agent or any other Secured Party
to make any such demand or to collect any payments from the Borrower or any other Grantor or any release of the Borrower or any other Grantor shall not relieve any Grantor in respect of which a demand or collection is not made or any Grantor not so
released of its several obligations or liabilities hereunder, and shall not impair or affect the rights and remedies, express or implied, or as a matter of law, of the Collateral Agent or any other Secured Party against any Grantor. For the purpose
hereof “demand” shall include the commencement and continuance of any legal proceedings. 
 5.6. Grant of
Intellectual Property License. For the purpose of enabling the Collateral Agent, during the continuance of an Event of Default and subject to the Intercreditor Agreement, to exercise rights and remedies hereunder at such time as the Collateral
Agent shall be lawfully entitled to exercise such rights and remedies, and for no other purpose, each Grantor hereby grants to the Collateral Agent an irrevocable, royalty-free, non-exclusive license to use, assign, license or sublicense any of the
Intellectual Property Collateral now owned or hereafter acquired by such Grantor, wherever the same may be located. This license shall include access to all media in which any of the licensed items may be recorded or stored and to all computer
programs used for the compilation or printout hereof. With respect to Trademarks licensed pursuant to this Section 5.6, the Collateral Agent shall use such Trademarks in accordance with Grantor’s reasonable trademark maintenance and use
standards and quality control requirements, (but no less than those that are sufficient to preserve the validity of such Trademarks), substantially consistent with Grantor’s past practices, and Collateral Agent shall cause any licensees and/or
sublicensees to enter into written agreements whereby they agree to comply with all such standards and quality control requirements, such agreements in form and substance reasonably satisfactory to the Collateral Agent. 

6. The Collateral Agent. 

6.1. Collateral Agent’s Appointment as Attorney-in-Fact, etc. 

(a) Each Grantor hereby appoints (until the Termination Date), which appointment is irrevocable and coupled with an interest, effective upon
the occurrence and during the continuation of an Event of Default, the Collateral Agent and any officer or agent thereof, with full power of substitution, as its true and lawful attorney-in-fact with full irrevocable power and authority in the place
and stead of such Grantor and in the name of such Grantor or otherwise, for the purpose of carrying out the terms of this Agreement and the other Loan Documents, to take any and all appropriate action and to execute any and all documents and
instruments which the Collateral Agent may deem necessary or desirable to accomplish the purposes of this Agreement and the other Loan Documents, and, without limiting the generality of the foregoing, each Grantor hereby gives the Collateral Agent
the power and right (until the Termination Date), on behalf of such Grantor, either in the Collateral Agent’s name or in the name of such Grantor or otherwise, without assent by such Grantor, to do any or all of the following at the same time
or at different times, in each case after the occurrence and during the continuation of an Event of Default and after written notice by the Collateral Agent of its intent to do so: 

(i) take possession of and endorse and collect any checks, drafts, notes, acceptances or other instruments for the payment of
moneys due under any Account or with respect to any other Collateral and file any claim or take any other action or proceeding in any court of law or equity or otherwise deemed appropriate by the Collateral Agent for the purpose of collecting any
and all such monies due under any Account or with respect to any other Collateral whenever payable; 

  
 -14- 

 (ii) in the case of any Intellectual Property, execute and deliver, and have
recorded, any and all agreements, instruments, documents and papers as the Collateral Agent may reasonably request to evidence the Collateral Agent’s and the Secured Parties’ security interest in such Intellectual Property and the goodwill
and general intangibles of such Grantor relating thereto or represented thereby; 
 (iii) pay or discharge Taxes and Liens
levied or placed on or threatened against any Collateral; 
 (iv) execute, in connection with any sale provided for in
Section 5.3, any endorsements, assignments or other instruments of conveyance or transfer with respect to the Collateral; 

(v) obtain, pay and adjust insurance required to be maintained by such Grantor or paid to the Collateral Agent pursuant to the
Term Loan Agreement; 
 (vi) send verifications of Accounts to any Person who is or who may become obligated to any Grantor
under, with respect to or on account of an Account; 
 (vii) direct any party liable for any payment under any of the
Collateral to make payment of any and all monies due or to become due thereunder directly to the Collateral Agent or as the Collateral Agent shall direct; 

(viii) ask or demand for, collect and receive payment of and receipt for, any and all moneys, claims and other amounts due or
to become due at any time in respect of or arising out of any Collateral; 
 (ix) sign and endorse any invoices, freight or
express bills, bills of lading, storage or warehouse receipts, drafts against debtors, assignments, verifications, notices and other documents in connection with any of the Collateral; 

(x) commence and prosecute any suits, actions or proceedings at law or in equity in any court of competent jurisdiction to
collect the Collateral or any portion thereof and to enforce any other right in respect of any Collateral; 
 (xi) defend any
suit, action or proceeding brought against such Grantor with respect to any Collateral (with such Grantor’s consent (not to be unreasonably withheld or delayed) to the extent such action or its resolution could materially affect such Grantor or
any of its Affiliates in any manner other than with respect to its continuing rights in such Collateral; provided that such consent right shall not limit any other rights or remedies available to the Collateral Agent at law); 

(xii) settle, compromise or adjust any such suit, action or proceeding and, in connection therewith, give such discharges or
releases as the Collateral Agent may deem appropriate (with such Grantor’s consent (not to be unreasonably withheld or delayed) to the extent such action or its resolution could materially affect such Grantor or any of its Affiliates in any
manner other than with respect to its continuing rights in such Collateral; provided that such consent right shall not limit any other rights or remedies available to the Collateral Agent at law); 

  
 -15- 

 (xiii) assign, transfer or license any Intellectual Property Collateral
throughout the world for such term or terms, on such conditions, and in such manner, as the Collateral Agent shall in its reasonable business discretion determine; and 

(xiv) generally, sell, transfer, pledge and make any agreement with respect to or otherwise deal with any of the Collateral as
fully and completely as though the Collateral Agent were the absolute owner thereof for all purposes, and do, at the Collateral Agent’s option and such Grantor’s expense, at any time, or from time to time, all acts and things that the
Collateral Agent deems necessary to protect, preserve or realize upon the Collateral and the Collateral Agent’s and the Secured Parties’ security interests therein and to effect the intent of this Agreement, all as fully and effectively as
such Grantor might do. 
 Anything in this Section 6.l(a) to the contrary notwithstanding, the Collateral Agent agrees that it will not exercise any
rights under the power of attorney provided for in this Section 6.1(a) unless an Event of Default shall have occurred and be continuing. 

(b) If any Grantor fails to perform or comply with any of its agreements contained herein, the Collateral Agent, at its option, but without
any obligation so to do and solely for the purpose of enabling the Collateral Agent to exercise its rights and remedies hereunder for the benefit of the Secured Parties at such times, may perform or comply, or otherwise cause performance or
compliance, with such agreement. 
 (c) Each Grantor hereby ratifies all that said attorney shall lawfully do or cause to be done by virtue
hereof. All powers, authorizations and agencies contained in this Agreement are coupled with an interest and are irrevocable until the Termination Date. 

6.2. Duty of Collateral Agent. The Collateral Agent’s sole duty with respect to the custody, safekeeping and
physical preservation of the Collateral in its possession, under Section 9-207 of the NY UCC or otherwise, shall be to deal with it in the same manner as the Collateral Agent deals with similar property for its own account. The Collateral Agent
shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral in its possession if such Collateral is accorded treatment substantially equal to that which the Collateral Agent accords its own property. The
Collateral Agent shall not be liable for failure to demand, collect or realize upon any of the Collateral or for any delay in doing so or shall be under any obligation to sell or otherwise dispose of any Collateral upon the request of any Grantor or
any other Person or to take any other action whatsoever with regard to the Collateral or any part thereof. The powers conferred on the Collateral Agent hereunder are solely to protect the Collateral Agent’s and the other Secured Parties’
interests in the Collateral and shall not impose any duty upon the Collateral Agent to exercise any such powers. The Collateral Agent shall be accountable only for amounts that it actually receives as a result of the exercise of such powers, and it
shall not be responsible to any Grantor for any act or failure to act hereunder, except for its own gross negligence, bad faith or willful misconduct or reckless disregard of its duties hereunder (as determined by a final, non-appealable judgment of
a court of competent jurisdiction) or material breach of this Agreement or the other Loan Documents. 
 6.3. Authority of
Collateral Agent. Each Grantor acknowledges that the rights and responsibilities of the Collateral Agent under this Agreement with respect to any action taken by the Collateral Agent or the exercise or non-exercise by the Collateral Agent of any
option, voting right, request, judgment or other right or remedy provided for herein or resulting or arising out of this Agreement shall, as between the Collateral Agent and the other Secured Parties, be governed by this Agreement and by such other
agreements with respect thereto as may exist from time to time among them, but, as between the Collateral Agent and the Grantors, the Collateral Agent shall be conclusively 

  
 -16- 

 
presumed to be acting as agent for the Secured Parties with full and valid authority so to act or refrain from acting, and no Grantor shall be under any obligation, or entitlement, to make any
inquiry respecting such authority. 
 6.4. Security Interest Absolute. All rights of the Collateral Agent hereunder,
the Security Interests created hereby and all obligations of the Grantors hereunder shall be absolute and unconditional irrespective of (a) any lack of validity or enforceability of the Term Loan Agreement, any other Loan Document, any
agreement with respect to any of the Secured Obligations or any other agreement or instrument relating to any of the foregoing, (b) any change in the time, manner or place of payment of, or in any other term of, all or any of the Secured
Obligations, or any other amendment or waiver of or any consent to any departure from the Term Loan Agreement, any other Loan Document, or any other agreement or instrument, (c) any exchange, release or non-perfection of any Lien on other
collateral, or any release or amendment or waiver of or consent under or departure from any guarantee, securing or guaranteeing all or any of the Secured Obligations, or (d) any other circumstance that might otherwise constitute a defense
available to, or a discharge of, any Grantor in respect of the Secured Obligations or this Agreement. 
 6.5. Continuing
Security Interest; Assignments Under the Loan Documents; Release. 
 (a) This Agreement shall remain in full force and effect and be
binding in accordance with and to the extent of its terms upon each Grantor and the successors and assigns thereof and shall inure to the benefit of the Collateral Agent and the other Secured Parties and their respective successors, indorsees,
transferees and assigns until the Termination Date. 
 (b) A Grantor shall automatically be released from its obligations hereunder and the
Security Interests of such Grantor created hereby shall be automatically released upon the consummation of any transaction permitted by the Term Loan Agreement or, if not permitted by the Term Loan Agreement, upon the effectiveness of any consent by
the Required Lenders or Lenders, as applicable, as a result of which such Grantor ceases to be a Restricted Subsidiary of Holdings or otherwise becomes an Excluded Subsidiary. 

(c) (i) Upon any sale, disposition or other transfer by any Grantor of any Collateral that is permitted under the Term Loan Agreement
(other than to another Grantor), (ii) upon the effectiveness of any written consent to the release of the Security Interests created hereby in any Collateral pursuant to Section 11.1 of the Term Loan Agreement, or (iii) as required by
the Intercreditor Agreement, the Security Interests in such Collateral created hereby shall be automatically released and such Collateral sold free and clear of the Lien and Security Interests created hereby. 

(d) In connection with any termination or release pursuant to paragraph (a), (b) or (c), the Collateral Agent shall promptly execute and
deliver to any Grantor or authorize the filing of, at such Grantor’s expense, all documents that such Grantor shall reasonably request to evidence such termination or release; provided that, with respect to the release of any Collateral
pursuant to clauses (b), (c)(i) and (c)(iii) above, the Collateral Agent shall have received such certifications and documentation as it shall reasonably request. Any execution and delivery of documents pursuant to this Section 6.5 shall be
without recourse to or warranty by the Collateral Agent. 
 6.6. Reinstatement. This Agreement shall continue to be
effective, or be reinstated, as the case may be, if at any time payment, or any part thereof, of any of the Secured Obligations is rescinded or must otherwise be restored or returned by the Collateral Agent or any other Secured Party upon the
insolvency, bankruptcy, dissolution, liquidation or reorganization of the Borrower or any other 

  
 -17- 

 
Grantor, or upon or as a result of the appointment of a receiver, intervenor or conservator of, or trustee or similar officer for, the Borrower or any other Grantor or any substantial part of its
property, or otherwise, all as though such payments had not been made. 
 6.7. Enforcement. No Secured Party (other
than the Collateral Agent) shall have any individual right to pursue any remedies under this Agreement or the other Loan Documents against any Grantor. 

7. Miscellaneous. 

7.1. Amendments in Writing. None of the terms or provisions of this Agreement may be waived, amended, supplemented or
otherwise modified except by a written instrument executed by the affected Grantor and the Collateral Agent in accordance with Section 11.1 of the Term Loan Agreement; provided, however, that this Agreement may be supplemented
(but no existing provisions may be modified and no Collateral may be released) through agreements substantially in the form of Exhibit 1, respectively, in each case duly executed by each Grantor directly affected thereby. 

7.2. Notices. All notices, requests and demands to or upon the Collateral Agent or any Grantor hereunder shall be
effected in the manner provided for in Section 11.3 of the Term Loan Agreement; provided, however, that any such notice, request or demand to or upon any Grantor shall be addressed to the Borrower’s notice address set forth
in such Section 11.3. 
 7.3. No Waiver by Course of Conduct; Cumulative Remedies. Neither the Collateral Agent
nor any other Secured Party shall by any act (except by a written instrument pursuant to Section 7.1 hereof), delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to have acquiesced in any Event of
Default or in any breach of any of the terms and conditions hereof or of any other applicable Loan Document. No failure to exercise, nor any delay in exercising, on the part of the Collateral Agent or any other Secured Party, any right, power or
privilege hereunder shall operate as a waiver thereof. No single or partial exercise of any right, power or privilege hereunder shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. A waiver by
the Collateral Agent or any other Secured Party of any right or remedy hereunder on any one occasion shall not be construed as a bar to any right or remedy that the Collateral Agent or such other Secured Party would otherwise have on any other
occasion. The rights, remedies, powers and privileges herein provided are cumulative, may be exercised singly or concurrently and are not exclusive of any other rights or remedies provided by law. 

7.4. Expenses. 

(a) Each Grantor agrees to pay any and all reasonable, documented and invoiced out-of-pocket costs and expenses in accordance with
Section 11.2 of the Term Loan Agreement. 
 (b) Any such amounts payable as provided hereunder shall be additional Secured Obligations
secured hereby and by the other Security Documents. The agreements in this Section 7.4 shall survive the Termination Date and the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document. 

7.5. Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and assigns permitted hereby, except that no Grantor may assign, transfer or delegate any of its rights or obligations under this Agreement without the prior written consent of the Collateral Agent,
except pursuant to a transaction expressly permitted by the Term Loan Agreement. 

  
 -18- 

 7.6. Counterparts. This Agreement may be executed by one or more of the
parties to this Agreement on any number of separate counterparts (including by facsimile or other electronic transmission (i.e. a “pdf” or “tif”), which delivery shall be effective as delivery of a manually executed counterpart),
and all of said counterparts taken together shall be deemed to constitute one and the same instrument. A set of the copies of this Agreement signed by all the parties shall be lodged with the Collateral Agent and the Borrower. 

7.7. Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction. The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as
possible to that of the invalid, illegal or unenforceable provisions. 
 7.8. Section Headings. The Section headings
used in this Agreement are for convenience of reference only and are not to affect the construction hereof or be taken into consideration in the interpretation hereof. 

7.9. Integration. This Agreement represents the agreement of each of the Grantors with respect to the subject matter
hereof and there are no promises, undertakings, representations or warranties by the Collateral Agent or any other Secured Party relative to the subject matter hereof not expressly set forth or referred to herein or in the other Loan Documents. 

7.10. GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND
CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 
 7.11. Submission To Jurisdiction
Waivers. Each party hereto irrevocably and un-conditionally: 
 (a) submits for itself and its property in any legal action or proceeding
relating to this Agreement and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction of the courts of the State of New York, the courts of the
United States of America for the Southern District of New York, and appellate courts from any thereof; 
 (b) consents that any such action
or proceeding shall be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and
agrees not to plead or claim the same; 
 (c) agrees that service of process in any such action or proceeding may be effected by mailing a
copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such party at its address referred to in Section 7.2 or at such other address of which any other party shall have been notified
pursuant thereto; and 
 (d) waives, to the maximum extent not prohibited by Applicable Law, any right it may have to claim or recover in
any legal action or proceeding referred to in this Section 7.11 any special, exemplary, punitive or consequential damages. 

  
 -19- 

 7.12. Acknowledgments. Each Grantor hereby acknowledges that: 

(a) it has been advised by counsel in the negotiation, execution and delivery of this Agreement and the other Loan Documents to which it is a
party; 
 (b) neither the Collateral Agent nor any other Secured Party has any fiduciary duty to any Grantor arising out of or in connection
with this Agreement or any of the other Loan Documents, and the relationship between the Grantors, on the one hand, and the Collateral Agent and the other Secured Parties, on the other hand, in connection herewith or therewith is solely that of
debtor and creditor; 
 (c) no joint venture is created hereby or by the other Loan Documents or otherwise exists by virtue of the
transactions contemplated hereby among the Secured Parties or among the Grantors and the Secured Parties; and 
 (d) upon any Event of
Default, the Collateral Agent may proceed against any Grantor and any Collateral in accordance with this Agreement and Applicable Law to collect and recover the full amount of any Secured Obligation then due, without first proceeding against any
other Grantor or any other Collateral and without first joining any other Grantor in any proceeding. 
 7.13. Additional
Grantors. Each Subsidiary of the Borrower that is required to become a party to this Agreement pursuant to Section 5.10 of the Term Loan Agreement and the terms hereof shall become a Grantor, with the same force and effect as if originally
named as a Grantor herein, for all purposes of this Agreement upon execution and delivery by such Subsidiary of a Supplement substantially in the form of Exhibit 1 hereto. The execution and delivery of any instrument adding an additional Grantor as
a party to this Agreement shall not require the consent of any other Grantor hereunder. The rights and obligations of each Grantor hereunder shall remain in full force and effect notwithstanding the addition of any new Grantor as a party to this
Agreement. 
 7.14. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AND THE TRANSACTIONS CONTEMPLATED THEREBY. 

7.15. Intercreditor Agreement Governs. Notwithstanding anything herein to the contrary, this Agreement, the Liens and
security interests granted to the Collateral Agent, for the benefit of the Secured Parties, pursuant to this Agreement and the exercise of any right or remedy by the Collateral Agent and the other Secured Parties hereunder, in each case, with
respect to the Revolving Priority Collateral and Revolving Liens are subject to the provisions of the Intercreditor Agreement. In the event of any conflict or inconsistency between the provisions of the Intercreditor Agreement and this Agreement
with respect to the Revolving Priority Collateral and Revolving Liens, the provisions of the Intercreditor Agreement shall prevail. Notwithstanding anything to the contrary contained in this Agreement or the Loan Documents, but subject to the
Intercreditor Agreement in all respects, until the Discharge of Revolving Obligations (as defined in the Intercreditor Agreement): (i) any covenant hereunder or under the Term Loan Agreement requiring (or any representation or warranty
hereunder or under the Term Loan Agreement to the extent it would have the effect of requiring) the delivery and/or arrangement for possession of Collateral that constitutes Revolving Priority Collateral or delivery and/or arrangement for control of
any certificated securities that constitute Revolving Priority Collateral to or with the Revolving Agent shall be deemed satisfied or complied with (or in the case of any representation or warranty, shall be deemed to be true and correct) if such
delivery and/or arrangement for possession of Collateral that constitutes Revolving Priority Collateral is made to, or such control of certificated 

  
 -20- 

 
securities is with the Revolving Agent pursuant to the Revolving Loan Documents; (ii) any covenant hereunder or under the Term Loan Agreement requiring (or any representation or warranty
hereunder or under the Term Loan Agreement to the extent it would have the effect of requiring ) the payment or other transfer of Collateral that constitutes Revolving Priority Collateral to the Collateral Agent shall be deemed to have been
satisfied (or, in the case of any representation or warranty, shall be deemed to be true and correct) if such payment or transfer shall have been made to the Revolving Agent; (iii) any covenant hereunder or under the Term Loan Agreement
requiring (or any representation or warranty hereunder or under the Term Loan Agreement to the extent it would have the effect of requiring) the endorsement of any Collateral that constitutes Revolving Priority Collateral or related document to the
Collateral Agent shall be deemed to have been satisfied (or, in the case of any representation or warranty, shall be deemed to be true and correct) if such endorsement shall have been made to the Revolving Collateral Agent; and (iv) any
covenant requiring that a Grantor receive and/or hold any Collateral that constitutes Revolving Priority Collateral in trust for the benefit of the Collateral Agent shall be deemed to have been satisfied to the extent that such Grantor receives or
holds (as applicable) such Collateral in trust for the benefit of the Revolving Collateral Agent and the Collateral Agent. 
 [Signature
Pages Follow] 

  
 -21- 

 IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be duly executed and
delivered as of the date first above written. 
  

					
	MILACRON LLC, as Grantor
		
	By:		/s/ Bruce A. Chalmers
			Name:		Bruce A. Chalmers
			Title:		Vice President Finance and Chief Financial Officer
	
	MILACRON INTERMEDIATE HOLDINGS INC.
	MCRON FINANCE CORP.,
			each as a Grantor
		
	By:		/s/ Bruce A. Chalmers
			Name:		Bruce A. Chalmers
			Title:		Vice President Finance, Chief Financial Officer and Treasurer
	
	DME COMPANY LLC
	CIMCOOL INDUSTRIAL PRODUCTS LLC
	MILACRON MARKETING COMPANY LLC
	MILACRON PLASTICS TECHNOLOGIES GROUP
	LLC,
			each as a Grantor
		
	By:		/s/ Bruce A. Chalmers
			Name:		Bruce A. Chalmers
			Title:		Chief Financial Officer and Treasurer
	
	KORTEC, INC., as Grantor
		
	By:		/s/ Bruce A. Chalmers
			Name:		Bruce A. Chalmers
			Title:		Vice President and Treasurer

  
 [Security Agreement]

 
			
	JPMORGAN CHASE BANK. NA., as Collateral Agent
		
	By:		/s/ Robert Bryant
			Name: Robert Bryant
			Title: Executive Director

  
 [Security Agreement]

 ANNEX A TO THE 

SECURITY AGREEMENT 

SUBSIDIARY GRANTORS 
 Subsidiary
Grantors 
  

	 	1.	Milacron Intermediate Holdings Inc. 

  

	 	2.	Milacron LLC 

  

	 	3.	Mcron Finance Corp. 

  

	 	4.	Milacron Marketing Company LLC 

  

	 	5.	Cimcool Industrial Products LLC 

  

	 	6.	Milacron Plastics Technologies Group LLC 

  

	 	7.	DME Company LLC 

  

	 	8.	Kortec, Inc. 

 Notice Address for All Grantors 

 

			
	Attention:		General Counsel
			Chief Financial Officer
		
	Address:		3010 Disney Street
			Cincinnati, OH 45209
		
	Phone:		(513) 487-5000
	Facsimile:		(513) 487-5086

 SCHEDULE 1 TO THE 

SECURITY AGREEMENT 

[List of Patents] 

 [List of Trademarks] 

 [List of Copyrights] 

 D. DOMAN NAMES 
  

					
	Registrant	  	Domain Name	  	Expiration
Date
	 ABBA SYSTEMS, INC.
	  	ABBASYSTEMS.COM	  	8/17/2021
	 MILACRON LLC
	  	AUTOJECTORS.COM	  	2/13/2016
	 MILACRON LLC
	  	BEMOREATMILACRON.COM	  	12/27/2021
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCLEAN.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.ASIA	  	6/30/2019
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.BE	  	3/30/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.BG	  	2/28/2016
	 MILACRON CANADA LTD.
	  	CIMCOOL.CA	  	3/28/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.CH	  	5/28/2019
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.CO.EE	  	9/24/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.CO.NO	  	7/2/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.CO.UK	  	7/13/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.CO.ZA	  	7/5/2017
	 MILACRON LLC
	  	CIMCOOL.COM	  	2/23/2017
	 MILACRON CANADA LTD.
	  	CIMCOOL.COM.MX	  	12/13/2015
	 CIMCOOLPOLAND
	  	CIMCOOL.COM.PL	  	2/23/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.COM.PT	  	6/28/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.COM.TR	  	4/27/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.COM.UA	  	12/10/2015
	 CIMCOOL EUROPE CZECH
	  	CIMCOOL.CZ	  	7/1/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.DE	  	11/23/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.ES	  	7/13/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.FR	  	2/25/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.GR	  	9/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.HU	  	10/1/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.IN	  	12/7/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.IT	  	2/26/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.LT	  	9/22/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.NET	  	8/7/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.NET.PL	  	12/7/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.NL	  	3/30/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.ORG	  	7/13/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.PL	  	2/23/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.RO	  	10/1/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.RU	  	9/28/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOL.SE	  	2/26/2016
	 REGISTRANT NOT REPORTED
	  	CIMCOOL.SK	  	6/7/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOLAPAC.COM	  	11/30/2020
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOLDENMARK.DK	  	9/24/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOLEUROPE.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMCOOLINDUSTRIALPRODUCTS.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMPERIAL.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMSTAR.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	CIMTECH.EU	  	4/29/2015

					
	Registrant	  	Domain Name	  	Expiration
Date
	 CIMCOOL INSDUSTRAIL PRODUCTS CN
	  	CINCINNATIMILACRON.NET	  	7/26/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	COOLANTS.EU	  	4/29/2015
	 MILACRON LLC
	  	DME.NET	  	1/11/2020
	 DME CHINA LTD
	  	DMECHINA.NET	  	8/31/2015
	 MILACRON LLC
	  	DMECO.COM	  	2/16/2018
	 DME COMPANY LLC
	  	DMECOMPANY.COM	  	6/8/2016
	 MILACRON LLC
	  	DMEEU.COM	  	3/28/2017
	 MILACRON LLC
	  	DMEUNIVERSITY.NET	  	7/23/2018
	 MILACRON MARKETING COMPANY LLC
	  	EDGEGATING.COM	  	12/17/2015
	 MILACRON MARKETING COMPANY LLC
	  	EHOTRUNNER.COM	  	1/8/2016
	 MILACRON MARKETING COMPANY LLC
	  	EHOTRUNNERS.COM	  	12/16/2015
	 MILACRON MARKETING COMPANY LLC
	  	E-HOTRUNNERS.COM	  	12/16/2015
	 MILACRON LLC
	  	EJECTORBLADES.COM	  	6/8/2016
	 MILACRON LLC
	  	EJECTORPINS.COM	  	6/8/2016
	 MILACRON LLC
	  	EJECTORSLEEVES.COM	  	6/8/2016
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	EVERYDROPISWORTHIT.EU	  	4/29/2015
	 MILACRON LLC
	  	EXTRUSIONSERVISES.COM	  	8/25/2015
	 FERROMATIK MILACRON AG
	  	FERROMATIK.CH	  	
	 FERROMATIK MILACRON GMBH
	  	FERROMATIK.COM	  	3/8/2016
	 FERROMATIK MILACRON GMBH
	  	FERROMATIK.DE	  	
	 REGISTRANT NOT REPORTED
	  	FERROMATIK.DK	  	9/30/2015
	 REGISTRANT NOT REPORTED
	  	FERROMATIK.ORG	  	2/14/2016
	 MILACRON MARKETING COMPANY LLC
	  	HOTHALF.COM	  	2/1/2016
	 MILACRON MARKETING COMPANY LLC
	  	HOT-RUNNER.COM	  	11/24/2015
	 MILACRON LLC
	  	HOTRUNNERMOLDING.COM	  	6/7/2016
	 MILACRON LLC
	  	HOTRUNNERS.CA	  	4/29/2016
	 MILACRON MARKETING COMPANY LLC
	  	HOTRUNNERS.CO	  	5/8/2017
	 MILACRON MARKETING COMPANY LLC
	  	HOTRUNNERSONLINE.COM	  	11/28/2015
	 MILACRON LLC
	  	HOTRUNNERSYSTEMS.COM	  	6/8/2016
	 MILACRON MARKETING COMPANY LLC
	  	IMSIPLASTICS.COM	  	6/4/2017
	 KORTEC, INC.
	  	KORTEC.COM	  	5/1/2017
	 MILACRON MARKETING COMPANY LLC
	  	MASTERPETSYSTEMS.COM	  	9/24/2015
	 MILACRON LLC
	  	MASTERUNITDIE.COM	  	10/1/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	METALWORKINGFLUIDS.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	MILACOOL.EU	  	4/19/2015
	 REGISTRANT NOT REPORTED
	  	MILACORN.EU	  	1/8/2016
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.AT	  	1/8/2016
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.CA	  	1/8/2016
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.CH	  	1/8/2016
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.CO.UK	  	1/8/2016
	 MILACRON LLC
	  	MILACRON.COM	  	12/29/2019
	 REGISTRANT NOT REPORTED
	  	MILACRON.COM.CN	  	12/20/2018
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.DE	  	1/8/2016
	 MILACRON LLC
	  	MILACRON.ES	  	1/22/2016
	 REGISTRANT NOT REPORTED
	  	MILACRON.FR	  	1/22/2016
	 MILACRON LLC
	  	MILACRON.HK	  	1/23/2016
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.IN	  	1/23/2016

					
	Registrant	  	Domain Name	  	Expiration
Date
	 MILACRON MARKETING COMPANY LLC
	  	MILACRON.JP	  	1/31/2016
	 REGISTRANT NOT REPORTED
	  	MILACRON.KR	  	1/22/2016
	 REGISTRANT NOT REPORTED
	  	MILACRON.MX	  	1/8/2016
	 MILACRON LLC
	  	MILACRON.NET	  	3/28/2019
	 MILACRON LLC
	  	MILACRON.ORG	  	3/28/2019
	 MILACRON LLC
	  	MILACRONAFTERMARKET.COM	  	7/1/2023
	 MILACRON MARKETING COMPANY LLC
	  	MILACRONCERTIFIED.COM	  	12/5/2018
	 MILACRON LLC
	  	MILACRONINDIA.COM	  	6/30/2015
	 MILACRON MARKETING COMPANY LLC
	  	MILACRONMACHINING.BIZ	  	9/23/2017
	 MILACRON MARKETING COMPANY LLC
	  	MILACRONMACHINING.COM	  	1/26/2018
	 MILACRON MARKETING COMPANY LLC
	  	MILACRONMACHINING.NET	  	1/26/2018
	 MILACRON MARKETING COMPANY LLC
	  	MILACRONPREOWNED.COM	  	12/5/2018
	 MILACRON MARKETING COMPANY LLC
	  	MILACRONUSED.COM	  	12/5/2018
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	MILFORM.EU	  	4/29/2015
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	MILPRO.EU	  	4/29/2015
	 MILACRON MARKETING COMPANY LLC
	  	MMHOTRUNNERS.COM	  	11/28/2015
	 MILACRON LLC
	  	MOLDACTION.COM	  	6/7/2016
	 MILACRON LLC
	  	MOLDASSEMBLIES.COM	  	6/7/2016
	 MILACRON LLC
	  	MOLDBASES.COM	  	6/7/2016
	 MILACRON LLC
	  	MOLDCOMPONENTS.COM	  	6/7/2016
	 MILACRON LLC
	  	MOLDCOOLING.COM	  	6/7/2016
	 MILACRON LLC
	  	MOLDINGUNDERCUTS.COM	  	7/28/2016
	 MILACRON LLC
	  	MOLDMASTER.CA	  	11/28/2015
	 MILACRON MARKETING COMPANY LLC
	  	MOLD-MASTER.COM	  	11/28/2017
	 MILACRON LLC
	  	MOLDMASTERS.CA	  	1/19/2017
	 MILACRON LLC
	  	MOLD-MASTERS.CA	  	11/28/2015
	 REGISTRANT NOT REPORTED
	  	MOLDMASTERS.CN	  	11/16/2017
	 MILACRON MARKETING COMPANY LLC
	  	MOLDMASTERS.CO	  	4/8/2017
	 MILACRON MARKETING COMPANY LLC
	  	MOLD-MASTERS.CO	  	5/8/2017
	 MILACRON MARKETING COMPANY LLC
	  	MOLDMASTERS.COM	  	1/18/2018
	 MILACRON MARKETING COMPANY LLC
	  	MOLD-MASTERS.COM	  	11/28/2017
	 MOLD-MASTERS LIMITED
	  	MOLDMASTERS.ES	  	8/11/2016
	 MOLD-MASTERS LIMITED
	  	MOLDMASTERS.IN	  	12/22/2015
	 MILACRON LLC
	  	MOLDMASTERS.MX	  	1/13/2017
	 MILACRON MARKETING COMPANY LLC
	  	MOLDMASTERS.NET	  	12/13/2016
	 MILACRON MARKETING COMPANY LLC
	  	MOLDMASTERS.ORG	  	12/13/2016
	 MILACRON LLC
	  	MOLDMONITOR.COM	  	7/23/2016
	 MILACRON LLC
	  	MOLDMONITOR.NET	  	7/23/2016
	 MILACRON LLC
	  	MOLDTOOLING.COM	  	6/7/2016
	 MILACRON MARKETING COMPANY LLC
	  	MPETSYSTEMS.COM	  	9/24/2015
	 MILACRON LLC
	  	NICKERSONMACHINERY.COM	  	10/13/2016
	 MILACRON LLC
	  	NORTHERNSUPPLY.COM	  	2/28/2016
	 MILACRON MARKETING COMPANY LLC
	  	OAKINTERNATIONAL.BIZ	  	12/5/2015
	 MILACRON LLC
	  	OAKINTERNATIONAL.COM	  	9/25/2017
	 CIMCOOL INDUSTRIAL PRODUCTS BV
	  	OAKINTERNATIONAL.EU	  	4/29/2015
	 MILACRON CANADA CORP
	  	OAKSIGNATURE.CA	  	12/14/2015
	 MILACRON LLC
	  	PLASTICSPROCESSING.COM	  	10/29/2017

					
	Registrant	  	Domain Name	  	Expiration
Date
	 MILACRON LLC
	  	PLASTICSTOOLING.COM	  	6/7/2016
	 MILACRON MARKETING COMPANY LLC
	  	PPMPLASTICS.COM	  	3/9/2018
	 MILACRON LLC
	  	PRODUCTOCHEMICALS.COM	  	8/16/2015
	 MILACRON LLC
	  	PRODUCTOCLEANERS.COM	  	3/10/2016
	 MILACRON LLC
	  	PROGRESSPRECISION.COM	  	9/13/2017
	 FERROMATIK MILACRON, INC.
	  	ROBOSHOT.COM	  	1/3/2016
	 FERROMATIK MILACRON, INC.
	  	ROBOSHOT.NET	  	1/3/2016
	 MILACRON LLC
	  	SERVTEK.COM	  	3/19/2017
	 MILACRON LLC
	  	SERVTEKPARTS.COM	  	6/30/2016
	 MILACRON MARKETING COMPANY LLC
	  	STACKMOLDS.COM	  	12/14/2016
	 MILACRON LLC
	  	STARCHEM.NET	  	5/23/2017
	 MILACRON LLC
	  	TEMPCONTROLS.COM	  	6/7/2016
	 MILACRON MARKETING COMPANY LLC
	  	TEMPMASTER.COM	  	12/15/2016
	 REGISTRANT NOT REPORTED
	  	TIRAD.CZ	  	11/7/2015
	 MILACRON UK LTD
	  	UNILOY.CO.UK	  	12/4/2016
	 MILACRON MARKETING COMPANY LLC
	  	UNILOY.COM	  	5/14/2032
	 UNILOY MILACRON GERMANY GMBH
	  	UNILOY.DE	  	
	 UNILOY MILACRON SRL
	  	UNILOY.IT	  	8/6/2015
	 MILACRON LLC
	  	UNILOY.NET	  	5/19/2020
	 MILACRON LLC
	  	UNILOY.US	  	5/19/2020
	 MILACRON MARKETING COMPANY LLC
	  	UNILOYMILACRON.COM	  	10/26/2016
	 UNILOY MILACRON GERMANY GMBH
	  	UNILOY-MILACRON.DE	  	
	 MILACRON LLC
	  	UNILOYNA.COM	  	5/19/2020
	 MILACRON LLC
	  	UNILOYNORTHAMERICA.COM	  	5/19/2020
	 MILACRON LLC
	  	UNILOYSPRINGFIELD.COM	  	5/19/2020
	 MILACRON LLC
	  	USEDEXTRUDERS.COM	  	8/5/2015
	 MILACRON MARKETING COMPANY LLC
	  	VALVEGATE.COM	  	12/17/2015
	 MILACRON MARKETING COMPANY LLC
	  	VALVEGATING.COM	  	12/17/2015
	 MILACRON LLC
	  	WEARTECHNOLOGY.COM	  	11/4/2016
	 MILACRON CANADA LTD
	  	YOURFLUIDDOCTOR.COM	  	10/31/2015

 SCHEDULE 2 TO THE 

SECURITY AGREEMENT 
 [List
of IP Agreements] 

 SCHEDULE 3 TO THE 

SECURITY AGREEMENT 

COMMERCIAL TORT CLAIMS 
 None. 

 EXHIBIT 1 TO THE 

SECURITY AGREEMENT 

SUPPLEMENT NO. [    ], dated as of [            ] (this
“Supplement”), to the Security Agreement, dated as of May 14, 2015 (as amended, restated, amended and restated, supplemented or otherwise modified, the “Security Agreement”), by and among MILACRON
INTERMEDIATE HOLDINGS INC., a Delaware corporation, MILACRON LLC, a Delaware limited liability company (the “Borrower”), each of the subsidiaries listed on Annex A thereto (together with the Borrower and
Holdings, collectively the “Grantors”), in favor of JPMORGAN CHASE BANK, N.A., in its capacity as collateral agent pursuant to the Term Loan Agreement, as pledgee, assignee and secured party (in such capacities and together
with any successors in such capacities, the “Collateral Agent”). 
 A. Capitalized terms used herein and not otherwise
defined herein (including terms used in the preamble and the recitals) shall have the meanings assigned to such terms in the Security Agreement. 

B. The rules of construction and other interpretive provisions specified in the Term Loan Agreement shall apply to this Supplement, including
terms defined in the preamble and recitals hereto. 
 C. Section 7.13 of the Security Agreement provides that each Restricted
Subsidiary of the Borrower that is required to become a party to the Security Agreement pursuant to Section 5.10 of the Term Loan Agreement and the terms hereof shall become a Grantor, with the same force and effect as if originally named as a
Grantor therein, for all purposes of the Security Agreement upon execution and delivery by such Subsidiary of an instrument in the form of this Supplement. Each undersigned Subsidiary (each, a “New Grantor”) is executing this
Supplement in accordance with the requirements of the Security Agreement to become a Grantor under the Security Agreement as consideration for the Secured Obligations. 

Accordingly, the Collateral Agent and the New Grantors agree as follows: 

SECTION 1. In accordance with Section 7.13 of the Security Agreement, each New Grantor by its signature below becomes a Grantor under the
Security Agreement with the same force and effect as if originally named therein as a Grantor and each New Grantor hereby (a) agrees to all the terms and provisions of the Security Agreement applicable to it as a Grantor thereunder and
(b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct in all material respects on and as of the date hereof (except where such representations and warranties expressly relate
to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date). In furtherance of the foregoing, each New Grantor, as security for the payment and performance
in full of the Secured Obligations, does hereby assign, pledge, mortgage and hypothecate to the Collateral Agent, for the benefit of the Secured Parties, and hereby grants to the Collateral Agent, for the benefit of the Secured Parties, a security
interest in all of the Collateral of such New Grantor, in each case whether now or hereafter existing or in which now has or hereafter acquires an interest (but, in any event, excluding any Excluded Assets). Each reference to a “Grantor”
in the Security Agreement shall be deemed to include each New Grantor. The Security Agreement (including Sections 2 and 7.15 thereof) is hereby incorporated herein by reference. 

SECTION 2. Each New Grantor represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly
authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, fraudulent conveyance,
reorganization, receivership, moratorium or similar laws affecting creditors’ rights generally and subject to general principles of equity (whether considered in a proceeding in equity or law). 

  
 Ex. 1-1 

 SECTION 3. This Supplement may be executed by one or more of the parties to this Supplement on
any number of separate counterparts (including by facsimile or other electronic transmission (i.e. a “pdf” or “tif”)), and all of said counterparts taken together shall be deemed to constitute one and the same instrument. This
Supplement shall become effective as to each New Grantor when the Collateral Agent shall have received counterparts of this Supplement that, when taken together, bear the signatures of such New Grantor and the Collateral Agent. 

SECTION 4. Such New Grantor hereby represents and warrants that (a) set forth on Schedule A attached hereto is (i) the legal name of
such New Grantor, (ii) the jurisdiction of organization or formation of such New Grantor, (iii) the identity or corporate structure of such New Grantor and (iv) the Federal Taxpayer Identification Number and organizational number of
such New Grantor and (b) as of the date hereof (i) Schedule B hereto sets forth all of the Registered Intellectual Property owned by a such New Grantor in its name, and indicates for each such item, as applicable, the application and/or
registration number, date and jurisdiction of filing and/or issuance, and the identity of the current applicant or registered owner, (ii) Schedule C hereto sets forth all Exclusive IP Agreements, (iii) Schedule D hereto sets forth all
Commercial Tort Claims held by such new Grantor and (iv) Schedule E hereto sets forth all Deposit Accounts of such New Grantor indicating if any such Deposit Accounts is an Excluded Deposit Account. 

SECTION 5. Except as expressly supplemented hereby, the Security Agreement shall remain in full force and effect. 

SECTION 6. THIS SUPPLEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 SECTION 7. Any provision of this Supplement that is prohibited or unenforceable
in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof and in the Security Agreement, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions
the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 
 SECTION 8. All
notices, requests and demands pursuant hereto shall be made in accordance with Section 11.3 of the Term Loan Agreement. All communications and notices hereunder to each New Grantor shall be given to it in care of the Borrower at the
Borrower’s address set forth in Section 11.3 of the Term Loan Agreement. 
 SECTION 9. Each New Grantor agrees to reimburse the
Collateral Agent for its reasonable, documented and invoiced out-of-pocket costs and expenses in connection with this Supplement in accordance with Section 11.2 of the Term Loan Agreement. 

  
 Ex. 1-2 

 IN WITNESS WHEREOF, each New Grantor and the Collateral Agent have duly executed this Supplement
to the Security Agreement as of the day and year first above written. 
  

			
	 [NEW GRANTOR(S)],

		
	 By:
		  

			 Name:

			 Title:

	
	 JPMORGAN CHASE BANK, N.A., as Collateral Agent

		
	 By:
		  

			 Name:

			 Title:

  
 Ex. 1-3 

 SCHEDULE A 

TO SUPPLEMENT NO.     TO THE 

SECURITY AGREEMENT 

CORPORATE INFORMATION 
  

							
	 Legal Name
	  	Jurisdiction of
Incorporation or
Organization	  	Type of Organization
or Corporate Structure	  	Federal Taxpayer
Identification
Number and
Organizational
Identification
Number
		  		  		  	

 SCHEDULE B 

TO SUPPLEMENT NO.     TO THE 

SECURITY AGREEMENT 

REGISTERED INTELLECTUAL PROPERTY 
  

	A.	COPYRIGHTS AND COPYRIGHT APPLICATIONS 

  

					
	 Registered

Owner/Grantor
	  	Title	  	Registration Number
		  		  	

  

	B.	PATENTS AND PATENT APPLICATIONS 

 Domestic Patent and Patent Applications

  

							
	 Registered

Owner/Grantor
	  	Patent	  	Registration
No.	  	Application
No.
		  		  		  	

  

	C.	TRADEMARKS AND TRADEMARK APPLICATIONS 

 Domestic Trademarks and Trademark
Applications 
  

							
	 Registered

Owner/Grantor
	  	Trademark	  	Registration
No.	  	Application
No.
		  		  		  	

  

	D.	DOMAIN NAMES 

 SCHEDULE C 

TO SUPPLEMENT NO.     TO THE 

SECURITY AGREEMENT 

EXCLUSIVE IP AGREEMENTS 

 SCHEDULE D 

TO SUPPLEMENT NO.     TO THE 

SECURITY AGREEMENT 

COMMERCIAL TORT CLAIMS 

 SCHEDULE E 

TO SUPPLEMENT NO.     TO THE 

SECURITY AGREEMENT 

ACCOUNTS 
  

													
	 Owner
	  	Type of
Account	  	Name of
Account	  	Bank or
Intermediary	  	Account
Numbers	  	Purpose of
Account	  	Excluded
Account
		  		  		  		  		  		  	

 EXHIBIT 2 TO THE 

SECURITY AGREEMENT 
 FORM
OF INTELLECTUAL PROPERTY SECURITY AGREEMENT 
 This INTELLECTUAL PROPERTY SECURITY AGREEMENT (the “IP Security
Agreement”), dated as of [            ], 20[    ], among the Person listed on the signature pages hereof (the “Grantor”), and JPMORGAN CHASE
BANK, N.A., as collateral agent for the Secured Parties (in such capacity, together with its successors in such capacity, the “Collateral Agent”). 

A. Capitalized terms used herein and not otherwise defined herein (including terms used in the preamble and the recitals) shall have the
meanings assigned to such terms in the Security Agreement, dated as of May 14, 2015 (as amended, restated, amended and restated, supplemented or otherwise modified, the “Security Agreement”), by and among MILACRON
INTERMEDIATE HOLDINGS INC., a Delaware corporation, MILACRON LLC, a Delaware limited liability company (the “Borrower”), each of the subsidiaries listed on Annex A thereto and the Collateral Agent. 

B. The rules of construction and other interpretive provisions specified in the Term Loan Agreement shall apply to this Supplement, including
terms defined in the preamble and recitals hereto. 
 C. Pursuant to Section 4.3(e) of the Security Agreement, the Grantor has agreed
to execute or otherwise authenticate this IP Security Agreement for recording the Security Interest granted under the Security Agreement to the Collateral Agent in the Grantor’s Registered Intellectual Property with the United States Patent and
Trademark Office and the United States Copyright Office and any other Governmental Authorities located in the United States necessary to perfect the Security Interest hereunder in such Registered Intellectual Property. 

Accordingly, the Collateral Agent and the Grantor agree as follows: 

SECTION 1. Grant of Security.3 The Grantor hereby grants to the Collateral Agent
for the benefit of the Secured Parties a security interest in all of the Grantor’s right, title and interest in and to the [United States Trademark registrations and applications] [United States Patent registrations and applications] [United
States Copyright registrations and applications and exclusive copyright licenses] set forth in Schedule A hereto, excluding any Excluded Assets (collectively, the “Collateral”). 

SECTION 2. Security for the Secured Obligations. The grant of a security interest in the Collateral by the Grantor under this IP
Security Agreement secures the payment of all amounts that constitute part of the Secured Obligations and would be owed to the Collateral Agent or the Secured Parties but for the fact that they are unenforceable or not allowable due to the existence
of a bankruptcy, reorganization or similar proceeding involving the Grantor. 
 SECTION 3. Recordation. The Grantor authorizes and
requests that the Register of Copyrights, the Commissioner for Patents, the Commissioner for Trademarks and any other applicable governmental officer located in the United States record this IP Security Agreement. 

 

	3 	Separate agreements should be entered in respect of patents, trademarks, and copyrights. 

  
 Ex. 3-1 

 SECTION 4. Grants, Rights and Remedies. This IP Security Agreement has been entered into
in conjunction with the provisions of the Security Agreement. The Grantor does hereby acknowledge and confirm that the grant of the security interest hereunder to, and the rights and remedies of, the Collateral Agent with respect to the Collateral
are more fully set forth in the Security Agreement, the terms and provisions of which are incorporated herein by reference as if fully set forth herein. In the event of any conflict between the terms of this IP Security Agreement and the terms of
the Security Agreement, the terms of the Security Agreement shall govern. 
 SECTION 5. Counterparts. This IP Security Agreement may
be executed by one or more of the parties to this IP Security Agreement on any number of separate counterparts (including by facsimile or other electronic transmission (i.e. a “pdf” or “tif”)), and all of said counterparts taken
together shall be deemed to constitute one and the same instrument. 
 SECTION 6. GOVERNING LAW. THIS IP SECURITY AGREEMENT AND
THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK AND APPLICABLE FEDERAL LAWS GOVERNING THE COLLATERAL. 

SECTION 7. Severability. Any provision of this IP Security Agreement that is prohibited or unenforceable in any jurisdiction shall, as
to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof and in the Security Agreement, and any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction. The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which
comes as close as possible to that of the invalid, illegal or unenforceable provisions. 
 SECTION 8. Notices. All notices, requests
and demands pursuant hereto shall be made in accordance with Section 11.3 of the Term Loan Agreement. All communications and notices hereunder to the Grantor shall be given to it in care of the Borrower at the Borrower’s address set forth
in Section 11.3 of the Term Loan Agreement. 
 SECTION 9. Expenses. The Grantor agrees to reimburse the Collateral Agent for its
reasonable, documented and invoiced out-of-pocket expenses in connection with this IP Security Agreement in accordance with Section 11.2 of the Term Loan Agreement. 

SECTION 10. Release of Security Interest. In connection with the termination or release of Security Interests evidenced by the Security
Agreement, the Collateral Agent shall execute and deliver to the Grantor, at the Grantor’s expense, all documents that the Grantor shall reasonably request to evidence such termination or release. 

SECTION 11. Intercreditor Agreement Governs. Notwithstanding anything herein to the contrary, this IP Security Agreement, the Liens and
security interests granted to the Collateral Agent, for the benefit of the Secured Parties, pursuant to this IP Security Agreement and the exercise of any right or remedy by the Collateral Agent and the other Secured Parties hereunder, in each case,
with respect to the Revolving Priority Collateral and Revolving Liens are subject to the provisions of the Intercreditor Agreement. In the event of any conflict or inconsistency between the provisions of the Intercreditor Agreement and this IP
Security Agreement with respect to the Revolving Priority Collateral and the Revolving Liens, the provisions of the Intercreditor Agreement shall prevail. 

  
 Ex. 3-2 

 IN WITNESS WHEREOF, the Grantor and the Collateral Agent have duly executed this IP Security
Agreement as of the day and year first above written. 
  

			
	[NAME OF GRANTOR],
		
	By:		  

			Name:
			Title:
	
	JPMORGAN CHASE BANK, N.A., as Collateral Agent
		
	By:		  

			Name:
			Title:

  
 Ex. 3-2 

 SCHEDULE A TO THE 

INTELLECTUAL PROPERTY 
 SECURITY
AGREEMENT 
 UNITED STATES TRADEMARKS/UNITED STATES PATENTS/ 

UNITED STATES COPYRIGHTS 

  
 Schedule AEX-10.5

 Exhibit 10.5 

MILACRON HOLDINGS CORP. 

2015 EQUITY INCENTIVE PLAN 

1. Purpose. 
 1.1 The
purpose of the Milacron Holdings Corp. 2015 Equity Incentive Plan is to further align the interests of eligible participants with those of the Company’s stockholders by providing long-term incentive compensation opportunities tied to the
performance of the Company and its Common Stock. The Plan is intended to advance the interests of the Company and increase stockholder value by attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the
successful conduct of the Company’s business is largely dependent. 
 2. Definitions. Wherever the following capitalized terms
are used in the Plan, they shall have the meanings specified below: 
 “Award” means an award of a Stock Option,
Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit, Cash Performance Award or Stock Award granted under the Plan. 

“Award Agreement” means a notice or an agreement entered into between the Company and a Participant setting forth the
terms and conditions of an Award granted to a Participant as provided in Section 15.2 hereof. 
 “Beneficial
Owner” shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act. 
 “Board”
means the Board of Directors of the Company. 
 “Cash Performance Award” means an Award that is denominated by
a cash amount to an Eligible Person under Section 10 hereof and payable based on or conditioned upon the attainment of pre-established business and/or individual Performance Goals over a specified performance period. 

“Cause” shall have the meaning set forth in Section 13.2 hereof. 

“Change in Control” shall have the meaning set forth in Section 12.2 hereof. 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Committee” means (i) the Compensation Committee of the Board, (ii) such other committee of the Board
appointed by the Board to administer the Plan or (iii) as provided in Section 3.1 hereof, the full Board. 

“Common Stock” means the Company’s common stock, par value $0.01 per share, as the same may be reclassified,
exchanged or recapitalized. 

 “Company” means Milacron Holdings Corp., a Delaware corporation or any
successor thereto.  
 “Date of Grant” means the date on which an Award under the Plan is granted or approved
for grant by the Committee or such later date as the Committee may specify to be the effective date of an Award. 

“Disability” shall have the meaning set forth below, except with respect to any Participant who has an effective
employment agreement or service agreement with the Company or one of its Subsidiaries that defines “Disability” or a like term, in which event the definition of “Disability” as set forth in such agreement shall be deemed to be
the definition of “Disability” herein solely for such Participant and only for so long as such agreement remains effective. In all other events, the term “Disability” shall mean Participant’s inability to perform the
essential duties, responsibilities and functions of Participant’s position with the Company and its Subsidiaries for a period of ninety (90) consecutive days or for a total of 180 days during any twelve (12) month period as a result
of any mental or physical illness, disability or incapacity even with reasonable accommodations for such illness, disability or incapacity provided by the Company and its Subsidiaries or if providing such accommodations would be unreasonable and
which condition is expected to last for a continuous period of not less than twelve (12) months, all as determined by the Committee in its reasonable good faith judgment. Participant shall cooperate in all respects with the Company if a
question arises as to whether he has become disabled (including, without limitation, submitting to reasonable examinations by one or more medical doctors and other health care specialists selected by the Company and authorizing such medical doctors
and other health care specialists to discuss Participant’s condition with the Company). 
 “Effective
Date” shall have the meaning set forth in Section 16.1 hereof. 
 “Eligible Person” means any
person who is an employee, Non-Employee Director, consultant or other personal service provider of the Company or any of its Subsidiaries. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder from time to time. 
 “Fair Market Value” means, with respect to a share of Common Stock as of a
given date of determination hereunder, the closing price as reported on the New York Stock Exchange or other principal exchange on which the Common Stock is then listed on such date, or if the Common Stock was not traded on such date, then on the
next preceding trading day that the Common Stock was traded on such exchange, as reported by such responsible reporting service as the Committee may select. If the Common Stock is not listed on any such exchange, “Fair Market Value” shall
be such value as determined by the Board in its discretion and, to the extent necessary, shall be determined in a manner consistent with Section 409A of the Code and the regulations thereunder. 

“Incentive Stock Option” means a Stock Option granted under Section 6 hereof that is intended to meet the
requirements of Section 422 of the Code and the regulations thereunder. 

  
 2 

 “Non-Employee Director” means a member of the Board who is not an
employee of the Company or any of its Subsidiaries. 
 “Nonqualified Stock Option” means a Stock Option
granted under Section 6 hereof that is not an Incentive Stock Option. 
 “Participant” means any Eligible
Person who holds an outstanding Award under the Plan. 
 “Performance Criteria” shall have the meaning set
forth in Section 10.3 hereof. 
 “Performance Goals” shall have the meaning set forth in
Section 10.4 hereof. 
 “Performance Stock Unit” means a Restricted Stock Unit denominated as a
Performance Stock Unit under Section 9.2 hereof, to be paid or distributed based on or conditioned upon the attainment of pre-established business and/or individual Performance Goals over a specified performance period. 

“Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections
13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) thereof. 
 “Plan”
means the Milacron Holdings Corp. 2015 Equity Incentive Plan as set forth herein, effective and as may be amended from time to time as provided herein. 

“Public Offering” means the sale of shares of the Common Stock to the public pursuant to an effective registration
statement (other than a registration statement on Form S-4 or S-8 or any similar or successor form) filed under the Securities Act in connection with an
underwritten offering. 
 “Restricted Stock Award” means a grant of shares of Common Stock to an Eligible
Person under Section 8 hereof that are issued subject to such vesting and transfer restrictions as the Committee shall determine, and such other conditions, as are set forth in the Plan and the applicable Award Agreement. 

“Restricted Stock Unit” means a contractual right granted to an Eligible Person under Section 9 hereof
representing notional unit interests equal in value to a share of Common Stock to be paid or distributed at such times, and subject to such conditions, as set forth in the Plan and the applicable Award Agreement. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder from time
to time. 
 “Service” means a Participant’s employment with the Company or any Subsidiary or a
Participant’s service as a Non-Employee Director, consultant or other service provider with the Company or any Subsidiary, as applicable. 

  
 3 

 “Stock Appreciation Right” means a contractual right granted to an
Eligible Person under Section 7 hereof entitling such Eligible Person to receive a payment, representing the excess of the Fair Market Value of a share of Common Stock over the base price per share of the right, at such time, and subject to
such conditions, as are set forth in the Plan and the applicable Award Agreement. 
 “Stock Award” means a
grant of shares of Common Stock to an Eligible Person under Section 11 hereof that are issued free of transfer restrictions and forfeiture conditions. 

“Stock Option” means a contractual right granted to an Eligible Person under Section 6 hereof to purchase shares
of Common Stock at such time and price, and subject to such conditions, as are set forth in the Plan and the applicable Award Agreement. 

“Subsidiary” means an entity (whether or not a corporation) that is wholly or majority owned or controlled, directly or
indirectly, by the Company or any other affiliate of the Company that is so designated, from time to time, by the Committee, during the period of such affiliated status; provided, however, that with respect to Incentive Stock Options,
the term “Subsidiary” shall include only an entity that qualifies under Section 424(f) of the Code as a “subsidiary corporation” with respect to the Company. 

3. Administration. 

3.1 Committee Members. The Plan shall be administered by a Committee comprised of no fewer than two members of the Board who are
appointed by the Board to administer the Plan. To the extent deemed necessary by the Board, each Committee member shall satisfy the requirements for (i) an “independent director” under rules adopted by the New York Stock Exchange or
other principal exchange on which the Common Stock is then listed, (ii) a “nonemployee director” for purposes of such Rule 16b-3 under the Exchange Act and (iii) an “outside director” under Section 162(m) of the
Code. Notwithstanding the foregoing, the mere fact that a Committee member shall fail to qualify under any of the foregoing requirements shall not invalidate any Award made by the Committee which Award is otherwise validly made under the Plan.
Neither the Company nor any member of the Committee shall be liable for any action or determination made in good faith by the Committee with respect to the Plan or any Award thereunder. The Board shall have the authority to execute the powers of the
Committee under the Plan. 
 3.2 Committee Authority. The Committee shall have all powers and discretion necessary or
appropriate to administer the Plan and to control its operation, including, but not limited to, the power to (i) determine the Eligible Persons to whom Awards shall be granted under the Plan, (ii) prescribe the restrictions, terms and
conditions of all Awards, (iii) interpret the Plan and terms of the Awards, (iv) adopt rules for the administration, interpretation and application of the Plan as are consistent therewith, and interpret, amend or revoke any such rules,
(v) make all determinations with respect to a Participant’s Service and the termination of such Service for purposes of any Award, (vi) correct any defect(s) or omission(s) or reconcile any ambiguity(ies) or inconsistency(ies) in the
Plan or any Award thereunder, (vii) make all determinations it deems advisable for the administration of the Plan; (viii) to decide all disputes arising in connection with the Plan and to otherwise supervise the administration of the Plan;
(ix)  

  
 4 

 
subject to the terms of the Plan, amend the terms of an Award in any manner that is not inconsistent with the Plan, (x) accelerate the vesting or, to the extent applicable,
exercisability of any Award at any time (including, but not limited to, upon a Change in Control or upon termination of Service under certain circumstances, as set forth in the Award Agreement or otherwise), and (xi) adopt such procedures and
subplans as are necessary or appropriate to permit participation in the Plan by Eligible Person who are foreign nationals or employed outside of the United States. The Committee’s determinations under the Plan need not be uniform and may be
made by the Committee selectively among Participants and Eligible Persons, whether or not such persons are similarly situated. The Committee shall, in its discretion, consider such factors as it deems relevant in making its interpretations,
determinations and actions under the Plan including, without limitation, the recommendations or advice of any officer or employee of the Company or such attorneys, consultants, accountants or other advisors as it may select. All interpretations,
determinations, and actions by the Committee shall be final, conclusive, and binding upon all parties. 
 3.3 Delegation of
Authority. The Committee shall have the right, from time to time, to delegate in writing to one or more officers of the Company the authority of the Committee to grant and determine the terms and conditions of Awards granted under the Plan,
subject to the requirements of Section 157(c) of the Delaware General Corporation Law (or any successor provision) or such other limitations as the Committee shall determine. In no event shall any such delegation of authority be permitted with
respect to Awards granted to any member of the Board or to any Eligible Person who is subject to Rule 16b-3 under the Exchange Act or is a covered employee under Section 162(m) of the Code. The Committee shall also be permitted to delegate, to
any appropriate officer or employee of the Company, responsibility for performing certain ministerial functions under the Plan. In the event that the Committee’s authority is delegated to officers or employees in accordance with the foregoing,
all provisions of the Plan relating to the Committee shall be interpreted in a manner consistent with the foregoing by treating any such reference as a reference to such officer or employee for such purpose. Any action undertaken in accordance with
the Committee’s delegation of authority hereunder shall have the same force and effect as if such action was undertaken directly by the Committee and shall be deemed for all purposes of the Plan to have been taken by the Committee. 

4. Shares Subject to the Plan. 

4.1 Number of Shares Reserved. Subject to adjustment as provided in Section 4.5 hereof, the total number of shares of Common
Stock that are reserved for issuance under the Plan shall be [•] shares of Common Stock (the “Share Reserve”). Each share of Common Stock subject to an Award shall reduce the Share Reserve by one share; provided that Awards
that are required to be paid in cash pursuant to their terms shall not reduce the Share Reserve. Any shares of Common Stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares. 

4.2 Share Replenishment. To the extent that an Award granted under this Plan is canceled, expired, forfeited, surrendered,
settled by delivery of fewer shares than the number underlying the Award or otherwise terminated without delivery of the shares to the Participant, the shares of Common Stock retained by or returned to the Company will (i) not be deemed to have
been delivered under the Plan, (ii) be available for future Awards under the Plan, and (iii)  

  
 5 

 
increase the Share Reserve by one share for each share that is retained by or returned to the Company. Shares that are (i) withheld from an Award in payment of the exercise or purchase
price or taxes relating to such an Award or (ii) not issued or delivered as a result of the net settlement of an outstanding stock option or stock appreciation right will (i) not be deemed to have been delivered under the Plan,
(ii) be available for future Awards under the Plan, and (iii) increase the Share Reserve by one share for each share that is retained by or returned to the Company. In addition to the foregoing, any shares that become available for
issuance pursuant to Section 5.2 of the Mcron Acquisition Corp. 2012 Equity Incentive Plan (the “2012 Plan”) as a result of the forfeiture, cancellation or termination for no consideration of an award under the 2012 Plan will
(i) not be available for future awards under the 2012 Plan, (ii) be available for future Awards under this Plan, and (iii) increase the Share Reserve by one share for each share that is retained by or returned to the Company, subject
to a maximum of 2,000,000 shares. 
 4.3 Awards Granted to Eligible Persons Other Than Non-Employee Directors. For
purposes of complying with the requirements of Section 162(m) of the Code, the maximum number of shares of Common Stock that may be subject to each Award type that is granted to an Eligible Person other than a Non-Employee Director during any
calendar year shall be limited as follows (subject to adjustment as provided in Section 4.5 hereof): (i) 1,000,000 shares of Common Stock subject to Stock Options, (ii) 1,000,000 shares of Common Stock subject to Stock Appreciation
Rights, (iii) 1,000,000 shares of Common Stock subject to Restricted Stock Awards that vest in full or in part based on the attainment of Performance Goals, (iv) 750,000 shares of Common Stock subject to Restricted Stock Awards that vest
in full or in part based on continued employment over a stated period of time, (v) 1,000,000 shares of Common Stock subject to Restricted Stock Units that vest in full or in part based on the attainment of Performance Goals and
(vi) 750,000 shares of Common Stock subject to Restricted Stock Units that vest in full or in part based on continued employment over a stated period of time. 

4.4 Awards Granted to Non-Employee Directors. The maximum number of shares of Common Stock that may be subject to Stock Options,
Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Units and Stock Awards granted to any Non-Employee Director during any calendar year shall be limited to 750,000 shares of Common Stock for all such Award types in the aggregate
(subject to adjustment as provided in Section 4.5 hereof). 
 4.5 Adjustments. If there shall occur any change with
respect to the outstanding shares of Common Stock by reason of any recapitalization, reclassification, stock dividend, extraordinary cash dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock or
any merger, reorganization, consolidation, combination, spin-off, stock purchase or other similar corporate change or any other change affecting the Common Stock (other than regular cash dividends to shareholders of the Company), the Committee
shall, in the manner and to the extent it considers appropriate and equitable to the Participants and consistent with the terms of the Plan, cause an adjustment to be made to (i) the maximum number and kind of shares of Common Stock provided in
Sections 4.1, 4.3 and 4.4 hereof (including the maximum number of shares of Common Stock that may become payable to a Participant provided in Sections 4.3 and 4.4 hereof), (ii) the number and kind of shares of Common Stock, units or other
rights subject to then outstanding Awards, (iii) the exercise or base price for each share or unit or other right subject to then outstanding Awards, (iv) the maximum amount that may become payable to a Participant under Cash Performance
Awards  

  
 6 

 
provided in Section 10.6 hereof, and (v) any other terms of an Award that are affected by the event. Notwithstanding the foregoing, (a) any such adjustments shall, to the
extent necessary, be made in a manner consistent with the requirements of Section 409A of the Code and (b) in the case of Incentive Stock Options, any such adjustments shall, to the extent practicable, be made in a manner consistent with
the requirements of Section 424(a) of the Code. 
 5. Eligibility and Awards. 

5.1 Designation of Participants. Any Eligible Person may be selected by the Committee to receive an Award and become a
Participant. The Committee has the authority, in its discretion, to determine and designate from time to time those Eligible Persons who are to be granted Awards, the types of Awards to be granted, the number of shares of Common Stock or units
subject to Awards to be granted and the terms and conditions of such Awards consistent with the terms of the Plan. In selecting Eligible Persons to be Participants, and in determining the type and amount of Awards to be granted under the Plan, the
Committee shall consider any and all factors that it deems relevant or appropriate. Designation of a Participant in any year shall not require the Committee to designate such person to receive an Award in any other year or, once designated, to
receive the same type or amount of Award as granted to such Participant in any other year. 
 5.2 Determination of
Awards. The Committee shall determine the terms and conditions of all Awards granted to Participants in accordance with its authority under Section 3.2 hereof. An Award may consist of one type of right or benefit hereunder or of two or more
such rights or benefits granted in tandem. 
 5.3 Award Agreements. Each Award granted to an Eligible Person shall be
represented by an Award Agreement. The terms of all Awards under the Plan, as determined by the Committee, will be set forth in each individual Award Agreements as described in Section 15.2 hereof. 

6. Stock Options. 

6.1 Grant of Stock Options. A Stock Option may be granted to any Eligible Person selected by the Committee, except that an
Incentive Stock Option may only be granted to an Eligible Person satisfying the conditions of Section 6.7(a) hereof. Each Stock Option shall be designated on the Date of Grant, in the discretion of the Committee, as an Incentive Stock Option or
as a Nonqualified Stock Option. All Stock Options granted under the Plan are intended to comply with or be exempt from the requirements of Section 409A of the Code. 

6.2 Exercise Price. The exercise price per share of a Stock Option shall not be less than one hundred percent (100%) of the
Fair Market Value of a share of Common Stock on the Date of Grant. The Committee may in its discretion specify an exercise price per share that is higher than the Fair Market Value of a share of Common Stock on the Date of Grant. 

6.3 Vesting of Stock Options. The Committee shall, in its discretion, prescribe the time or times at which or the conditions upon
which, a Stock Option or portion thereof shall become vested and/or exercisable. The requirements for vesting and exercisability of a Stock Option may be based on the continued Service of the Participant with the Company or a 

  
 7 

 
Subsidiary for a specified time period (or periods), on the attainment of a specified Performance Goal(s) or on such other terms and conditions as approved by the Committee in its discretion,
all as set forth in the Award Agreement. If the vesting requirements of a Stock Option are not satisfied, the Award shall be forfeited. 

6.4 Term of Stock Options. The Committee shall in its discretion prescribe in an Award Agreement the period during which a vested
Stock Option may be exercised; provided, however, that the maximum term of a Stock Option shall be ten (10) years from the Date of Grant. The Committee may provide that a Stock Option will cease to be exercisable upon or at the
end of a specified time period following a termination of Service for any reason as set forth in the Award Agreement or otherwise. A Stock Option may be earlier terminated as specified by the Committee and set forth in an Award Agreement upon or
following the termination of a Participant’s Service with the Company or any Subsidiary, including by reason of voluntary resignation, death, Disability, termination for cause or any other reason. Subject to Section 409A of the Code and
the provisions of this Section 6, the Committee may extend at any time the period in which a Stock Option may be exercised.  

6.5 Stock Option Exercise; Tax Withholding. Subject to such terms and conditions as specified in an Award Agreement, a Stock
Option may be exercised in whole or in part at any time during the term thereof by notice in the form required by the Company, together with payment of the aggregate exercise price and applicable withholding tax. Payment of the exercise price may be
made: (i) in cash or by cash equivalent acceptable to the Committee or (ii) to the extent permitted by the Committee in its sole discretion and set forth in the Award Agreement or otherwise (including by a policy or resolution of the
Committee), (A) in shares of Common Stock valued at the Fair Market Value of such shares on the date of exercise, (B) through an open-market, broker-assisted sales transaction pursuant to which the Company is promptly delivered the amount
of proceeds necessary to satisfy the exercise price, (C) by reducing the number of shares of Common Stock otherwise deliverable upon the exercise of the Stock Option by the number of shares of Common Stock having a Fair Market Value on the date
of exercise equal to the exercise price, (D) by a combination of the methods described above or (E) by such other method as may be approved by the Committee and set forth in the Award Agreement. In addition to and at the time of payment of
the exercise price, the Participant shall pay to the Company the full amount of any and all applicable income tax, employment tax and other amounts required to be withheld in connection with such exercise, payable under such of the methods described
above for the payment of the exercise price as may be approved by the Committee and set forth in the Award Agreement. 
 6.6
Limited Transferability of Nonqualified Stock Options. All Stock Options shall be nontransferable except (i) upon the Participant’s death, in accordance with Section 15.3 hereof or (ii) in the case of Nonqualified Stock
Options only, for the transfer of all or part of the Stock Option to a Participant’s “family member” (as defined for purposes of the Form S-8 registration statement under the Securities Act of 1933), or as otherwise permitted by the
Committee, in each case as may be approved by the Committee in its discretion at the time of proposed transfer. The transfer of a Nonqualified Stock Option may be subject to such terms and conditions as the Committee may in its discretion impose
from time to time. Subsequent transfers of a Nonqualified Stock Option shall be prohibited other than in accordance with Section 15.3 hereof. 

  
 8 

 6.7 Additional Rules for Incentive Stock Options. 

(a) Eligibility. An Incentive Stock Option may only be granted to an Eligible Person who is considered an employee for purposes
of Treasury Regulation §1.421-1(h) with respect to the Company or any Subsidiary that qualifies as a “subsidiary corporation” with respect to the Company for purposes of Section 424(f) of the Code. 

(b) Annual Limits. No Incentive Stock Option shall be granted to a Participant as a result of which the aggregate Fair Market
Value (determined as of the Date of Grant) of the Common Stock with respect to which incentive stock options under Section 422 of the Code are exercisable for the first time in any calendar year under the Plan and any other stock option plans
of the Company or any subsidiary or parent corporation, would exceed $100,000, determined in accordance with Section 422(d) of the Code. This limitation shall be applied by taking Stock Options into account in the order in which granted.

 (c) Additional Limitations. In the case of any Incentive Stock Option granted to an Eligible Person who owns, either
directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any
Subsidiary, the exercise price shall not be less than one hundred ten percent (110%) of the Fair Market Value of a share of Common Stock on the Date of Grant and the maximum term shall be five (5) years. 

(d) Termination of Employment. An Award of an Incentive Stock Option may provide that such Stock Option may be exercised not
later than (i) three (3) months following termination of employment of the Participant with the Company and all Subsidiaries (other than as set forth in clause (ii) of this Section 6.7(d)) or (ii) one year following
termination of employment of the Participant with the Company and all Subsidiaries due to death or permanent and total disability within the meaning of Section 22(e)(3) of the Code, in each case as and to the extent determined by the Committee
to comply with the requirements of Section 422 of the Code. 
 (e) Other Terms and Conditions; Nontransferability.
Any Incentive Stock Option granted hereunder shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as are deemed necessary or desirable by the Committee, which terms, together with the terms of the Plan,
shall be intended and interpreted to cause such Incentive Stock Option to qualify as an “incentive stock option” under Section 422 of the Code. A Stock Option that is granted as an Incentive Stock Option shall, to the extent it fails
to qualify as an “incentive stock option” under the Code, be treated as a Nonqualified Stock Option. An Incentive Stock Option shall by its terms be nontransferable other than by will or by the laws of descent and distribution, and shall
be exercisable during the lifetime of a Participant only by such Participant. 
 (f) Disqualifying Dispositions. If
shares of Common Stock acquired by exercise of an Incentive Stock Option are disposed of within two years following the Date of Grant or one year following the transfer of such shares to the Participant upon exercise, the Participant shall, promptly
following such disposition, notify the Company in writing of the date and terms of such disposition and provide such other information regarding the disposition as the Company may reasonably require. 

  
 9 

 6.8 Repricing Prohibited. Subject to the anti-dilution adjustment provisions
contained in Section 4.5 hereof, without the prior approval of the Company’s stockholders, neither the Committee nor the Board shall cancel a Stock Option when the exercise price per share exceeds the Fair Market Value of one share of
Common Stock in exchange for cash or another Award (other than in connection with a Change in Control) or cause the cancellation, substitution or amendment of a Stock Option that would have the effect of reducing the exercise price of such a Stock
Option previously granted under the Plan or otherwise approve any modification to such a Stock Option that would be treated as a “repricing” under the then applicable rules, regulations or listing requirements adopted by the New York Stock
Exchange or other principal exchange on which the Common Stock is then listed.  
 6.9 Dividend Equivalent Rights.
Subject to the anti-dilution adjustment provisions contained in Section 4.5 hereof, dividends shall not be paid with respect to Stock Options. Dividend equivalent rights shall be granted with respect to the shares of Common Stock subject to
Stock Options to the extent permitted by the Committee or set forth in the Award Agreement. 
 7. Stock Appreciation Rights.

 7.1 Grant of Stock Appreciation Rights. Stock Appreciation Rights may be granted to any Eligible Person selected by the
Committee. Stock Appreciation Rights may be granted on a basis that allows for the exercise of the right by the Participant or that provides for the automatic payment of the right upon a specified date or event. Stock Appreciation Rights shall be
non-transferable, except as provided in Section 15.3 hereof. All Stock Appreciation Rights granted under the Plan are intended to comply with or otherwise be exempt from the requirements of Section 409A of the Code. 

7.2 Stand-Alone and Tandem Stock Appreciation Rights. A Stock Appreciation Right may be granted without any related Stock Option,
or may be granted in tandem with a Stock Option, either on the Date of Grant or at any time thereafter during the term of the Stock Option. The Committee shall in its discretion provide in an Award Agreement the time or times at which or the
conditions upon which, a Stock Appreciation Right or portion thereof shall become vested and/or exercisable. The requirements for vesting and exercisability of a Stock Appreciation Right may be based on the continued Service of a Participant with
the Company or a Subsidiary for a specified time period (or periods), on the attainment of a specified Performance Goal(s) or on such other terms and conditions as approved by the Committee in its discretion. If the vesting requirements of a Stock
Appreciation Right are not satisfied, the Award shall be forfeited. A Stock Appreciation Right will be exercisable or payable at such time or times as determined by the Committee; provided, that the maximum term of a Stock Appreciation Right
shall be ten (10) years from the Date of Grant. The Committee may provide that a Stock Appreciation Right will cease to be exercisable upon or at the end of a period following a termination of Service for any reason. The base price of a Stock
Appreciation Right granted without any related Stock Option shall be determined by the Committee in its discretion; provided, however, that the base price per share of any such stand-alone Stock Appreciation Right shall not be less
than one hundred percent (100%) of the Fair Market Value of a share of Common Stock on the Date of Grant. 

  
 10 

 7.3 Payment of Stock Appreciation Rights. A Stock Appreciation Right will entitle
the holder, upon exercise or other payment of the Stock Appreciation Right, as applicable, to receive an amount determined by multiplying: (i) the excess of the Fair Market Value of a share of Common Stock on the date of exercise or payment of
the Stock Appreciation Right over the base price of such Stock Appreciation Right, by (ii) the number of shares as to which such Stock Appreciation Right is exercised or paid. Payment of the amount determined under the foregoing may be made, as
approved by the Committee and set forth in the Award Agreement, in shares of Common Stock valued at their Fair Market Value on the date of exercise or payment, in cash or in a combination of shares of Common Stock and cash, subject to applicable tax
withholding requirements. 
 7.4 Repricing Prohibited. Subject to the anti-dilution adjustment provisions contained in
Section 4.5 hereof, without the prior approval of the Company’s stockholders, neither the Committee nor the Board shall cancel a Stock Appreciation Right when the base price per share exceeds the Fair Market Value of one share of Common
Stock in exchange for cash or another Award (other than in connection with a Change in Control) or cause the cancellation, substitution or amendment of a Stock Appreciation Right that would have the effect of reducing the base price of such a Stock
Appreciation Right previously granted under the Plan or otherwise approve any modification to such Stock Appreciation Right that would be treated as a “repricing” under the then applicable rules, regulations or listing requirements adopted
by the New York Stock Exchange or other principal exchange on which the Common Stock is then listed.  
 7.5 Dividend
Equivalent Rights. Subject to the anti-dilution adjustment provisions contained in Section 4.5 hereof, dividends shall not be paid with respect to Stock Appreciation Rights. Dividend equivalent rights shall be granted with respect to the
shares of Common Stock subject to Stock Appreciation Rights to the extent permitted by the Committee or set forth in the Award Agreement. 

8. Restricted Stock Awards. 

8.1 Grant of Restricted Stock Awards. A Restricted Stock Award may be granted to any Eligible Person selected by the Committee.
The Committee may require the payment by the Participant of a specified purchase price in connection with any Restricted Stock Award. 

8.2 Vesting Requirements. The restrictions imposed on shares granted under a Restricted Stock Award shall lapse in accordance
with the vesting requirements specified by the Committee in the Award Agreement. The requirements for vesting of a Restricted Stock Award may be based on the continued Service of the Participant with the Company or a Subsidiary for a specified time
period (or periods), on the attainment of a specified Performance Goal(s) designed to meet the requirements for exemption under Section 162(m) of the Code or on such other terms and conditions as approved by the Committee in its discretion. If
the vesting requirements of a Restricted Stock Award shall not be satisfied or, if applicable, the Performance Goal(s) with respect to such Restricted Stock Award are not attained, the Award shall be forfeited and the shares of Stock subject to the
Award shall be returned to the Company. 

  
 11 

 8.3 Transfer Restrictions. Shares granted under any Restricted Stock Award may not
be transferred, assigned or subject to any encumbrance, pledge or charge until all applicable restrictions are removed or have expired, except as provided in Section 15.3 hereof. Failure to satisfy any applicable restrictions shall result in
the subject shares of the Restricted Stock Award being forfeited and returned to the Company. The Committee may require in an Award Agreement that certificates (if any) representing the shares granted under a Restricted Stock Award bear a legend
making appropriate reference to the restrictions imposed, and that certificates (if any) representing the shares granted or sold under a Restricted Stock Award will remain in the physical custody of an escrow holder until all restrictions are
removed or have expired. 
 8.4 Rights as Stockholder. Subject to the foregoing provisions of this Section 8 and
the applicable Award Agreement, the Participant shall have all rights of a stockholder with respect to the shares granted to the Participant under a Restricted Stock Award, including the right to vote the shares and receive all dividends and other
distributions paid or made with respect thereto, unless otherwise provided in the applicable Award Agreement or the Committee determines otherwise at the time the Restricted Stock Award is granted. The Committee may provide in an Award Agreement for
the payment of dividends and distributions to the Participant at such times as paid to stockholders generally, at the times of vesting or other payment of the Restricted Stock Award or otherwise.  

8.5 Section 83(b) Election. If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a
Restricted Stock Award, the Participant shall file, within thirty (30) days following the Date of Grant, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under Section 83 of
the Code. The Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant’s making or refraining from making an election with respect to the Award under Section 83(b) of the Code.

 9. Restricted Stock Units. 

9.1 Grant of Restricted Stock Units. A Restricted Stock Unit may be granted to any Eligible Person selected by the Committee. The
value of each Restricted Stock Unit is equal to the Fair Market Value of the Common Stock on the applicable date or time period of determination, as specified by the Committee. Restricted Stock Units shall be subject to such restrictions and
conditions as the Committee shall determine. In addition, a Restricted Stock Unit may be designated as a “Performance Stock Unit”, the vesting requirements of which may be based, in whole or in part, on the attainment of pre-established
business and/or individual Performance Goal(s) over a specified performance period designed to meet the requirements for exemption under Section 162(m) of the Code, or otherwise, as approved by the Committee in its discretion. Restricted Stock
Units shall be non-transferable, except as provided in Section 15.3 hereof. 
 9.2 Vesting of Restricted Stock
Units. On the Date of Grant, the Committee shall, in its discretion, determine any vesting requirements with respect to Restricted Stock Units, which shall be set forth in the Award Agreement. The requirements for vesting of a Restricted Stock
Unit may be based on the continued Service of the Participant with the Company or a Subsidiary for a specified time period (or periods) or on such other terms and conditions as approved by the Committee (including Performance Goal(s)) in its
discretion. If the vesting requirements of a Restricted Stock Units Award are not satisfied, the Award shall be forfeited. 

  
 12 

 9.3 Payment of Restricted Stock Units. Restricted Stock Units shall become payable
to a Participant at the time or times determined by the Committee and set forth in the Award Agreement, which may be upon or following the vesting of the Award. Payment of a Restricted Stock Unit may be made, as approved by the Committee and set
forth in the Award Agreement, in cash or in shares of Common Stock or in a combination thereof, subject to applicable tax withholding requirements. Any cash payment of a Restricted Stock Unit shall be made based upon the Fair Market Value of the
Common Stock. 
 9.4 Dividend Equivalent Rights. Subject to the anti-dilution adjustment provisions contained in
Section 4.5 hereof, Restricted Stock Units may or may not, in the discretion of the Committee, be granted together with a dividend equivalent right with respect to the shares of Common Stock subject to the Award, which may be accumulated and
may be deemed reinvested in additional Restricted Stock Units or may be accumulated in cash, as determined by the Committee in its discretion. Dividend equivalent rights will be paid at such times as determined by the Committee in its discretion
(including without limitation at the times paid to stockholders generally or at the times of vesting or payment of the Restricted Stock Unit). Dividend equivalent rights may be subject to forfeiture under the same conditions as apply to the
underlying Restricted Stock Units. 
 9.5 No Rights as Stockholder. The Participant shall not have any rights as a
stockholder with respect to the shares subject to a Restricted Stock Unit until such time as shares of Common Stock are delivered to the Participant pursuant to the terms of the Award Agreement. 

10. Cash Performance Awards and Performance Criteria. 

10.1 Grant of Cash Performance Awards. A Cash Performance Award may be granted to any Eligible Person selected by the Committee. Payment
amounts may be based on specified levels of attainment with respect to the Performance Goals, including, if applicable, specified threshold, target and maximum performance levels. The requirements for payment may be also based upon the continued
Service of the Participant with the Company or a Subsidiary during the respective performance period and on such other conditions as determined by the Committee and set forth in an Award Agreement. With respect to Cash Performance Awards and other
Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code, before the 90th day of the applicable performance period (or, if the performance period is less than one year, no later than the number
of days which is equal to 25% of such performance period), the Committee will determine the duration of the performance period, the Performance Criteria, the applicable Performance Goals relating to the Performance Criteria, and the amount and terms
of payment and/or vesting upon achievement of the Performance Goals. Cash Performance Awards shall be non-transferable, except as provided in Section 15.3 hereof. 

10.2 Award Agreements. Each Cash Performance Award shall be evidenced by an Award Agreement that shall specify the performance
period and such other terms and conditions as the Committee, in its discretion, shall determine. The Committee may accelerate the vesting of a Cash Performance Award upon a Change in Control or termination of Service under certain circumstances, as
set forth in the Award Agreement. 

  
 13 

 10.3 Performance Criteria. For purposes of Cash Performance Awards, Performance Stock
Units and other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code, the Performance Criteria shall be one or any combination of the following, for the Company or any identified Subsidiary
or business unit, as determined by the Committee before the 90th day of the applicable performance period: (a) net earnings; (b) earnings per share; (c) net debt; (d) revenue or sales growth; (e) net or operating income;
(f) net operating profit; (g) return measures (including, but not limited to, return on assets, capital, equity or sales); (h) cash flow (including, but not limited to, operating cash flow, distributable cash flow and free cash flow);
(i) earnings before or after taxes, interest, depreciation, amortization and/or rent; (j) share price (including, but not limited to growth measures and total stockholder return); (k) expense control or loss management;
(l) customer satisfaction; (m) market share; (n) economic value added; (o) working capital; (p) the formation of joint ventures or the completion of other corporate transactions; (q) gross or net profit margins;
(r) revenue mix; (s) operating efficiency; (t) product diversification; (u) market penetration; (v) measurable achievement in quality, operation or compliance initiatives; (w) quarterly dividends or distributions;
(x) employee retention or turnover; or (y) any combination of or a specified increase in any of the foregoing. Each of the Performance Criteria shall be applied and interpreted in accordance with an objective formula or standard
established by the Committee at the time the applicable Award is granted including, without limitation, GAAP. 
 10.4 Performance
Goals. For purposes of Cash Performance Awards and other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code, the “Performance Goals” shall be the levels of achievement
relating to the Performance Criteria selected by the Committee for the Award. The Performance Goals shall be written and shall be expressed as an objective formula or standard that precludes discretion to increase the amount of compensation payable
that would otherwise be due upon attainment of the goal. The Performance Goals may be applied on an absolute basis or relative to an identified index, peer group, or one or more competitors or other companies (including particular business segments
or divisions or such companies), as specified by the Committee. The Performance Goals need not be the same for all Participants. 
 10.5
Adjustments. At the time that an Award is granted, the Committee may provide for the Performance Goals or the manner in which performance will be measured against the Performance Goals to be adjusted in such objective manner as it deems
appropriate, including, without limitation, adjustments to reflect charges for restructurings, non-operating income, the impact of corporate transactions or discontinued operations, extraordinary and other unusual or non-recurring items and the
cumulative effects of accounting or tax law changes. In addition, with respect to a Participant hired or promoted following the beginning of a performance period, the Committee may determine to prorate the Performance Goals and/or the amount of any
payment in respect of such Participant’s Cash Performance Awards for the partial performance period. 
 10.6 Maximum Amount of Cash
Performance Awards. The maximum amount that may become payable to any one Participant during any one calendar year under all Cash Performance Awards intended to qualify as “performance-based compensation” under Section 162(m) of
the Code is limited to $15,000,000. 

  
 14 

 10.7 Negative Discretion. Notwithstanding anything else contained in the Plan to the
contrary, the Committee shall, to the extent provided in an Award Agreement, have the right, in its discretion, (i) to reduce or eliminate the amount otherwise payable to any Participant under an Award and (ii) to establish rules or
procedures that have the effect of limiting the amount payable to any Participant to an amount that is less than the amount that otherwise would be payable under an Award. The Committee may exercise such discretion in a non-uniform manner among
Participants. The Committee shall not have discretion to increase the amount that otherwise would be payable to any Participant under a Cash Performance Award or other Award intended to qualify as “performance-based compensation” under
Section 162(m) of the Code. 
 10.8 Certification. Following the conclusion of the performance period of a Cash Performance Award
or other Award intended to qualify as “performance-based compensation” under Section 162(m) of the Code, the Committee shall certify in writing whether the Performance Goals for that performance period have been achieved, or certify
the degree of achievement, if applicable. 
 10.9 Payment. Upon certification of the Performance Goals for a Cash Performance Award,
or other Award intended to qualify as “performance-based compensation” under Section 162(m) of the Code, the Committee shall determine the level of vesting or amount of payment to the Participant pursuant to the Award, if any.
Notwithstanding the foregoing, Cash Performance Awards may be paid, at the discretion of the Committee, in any combination of cash or shares of Common Stock, based upon the Fair Market Value of such shares at the time of payment. 

11. Stock Awards. 

11.1 Grant of Stock Awards. A Stock Award may be granted to any Eligible Person selected by the Committee. A Stock Award may be
granted for past Services, in lieu of bonus or other cash compensation, as directors’ compensation or for any other valid purpose as determined by the Committee. The Committee shall determine the terms and conditions of such Awards, and such
Awards may be made without vesting requirements. In addition, the Committee may, in connection with any Stock Award, require the payment of a specified purchase price. 

11.2 Rights as Stockholder. Subject to the foregoing provisions of this Section 11 and the applicable Award Agreement, upon
the issuance of the Common Stock under a Stock Award the Participant shall have all rights of a stockholder with respect to the shares of Common Stock, including the right to vote the shares and receive all dividends and other distributions paid or
made with respect thereto. 
 12. Change in Control. 

12.1 Effect on Awards. Upon the occurrence of a Change in Control, unless otherwise provided in the Award Agreement, the
Committee is authorized (but not obligated) to make adjustments in the terms and conditions of outstanding Awards, including without limitation the following (or any combination thereof): (a) continuation or assumption of such outstanding 

  
 15 

 
Awards under the Plan by the Company (if it is the surviving company or corporation) or by the surviving company or corporation or its parent; (b) substitution by the surviving company
or corporation or its parent of awards with substantially the same terms for outstanding Awards (with appropriate adjustments to the type of consideration payable upon settlement of the Awards); (c) accelerated exercisability, vesting and/or
payment under outstanding Awards immediately prior to the occurrence of such event or upon a termination of employment following such event; and (d) if all or substantially all of the Company’s outstanding shares of Common Stock
transferred in exchange for cash consideration in connection with such Change in Control: (i) upon written notice, provide that any outstanding Stock Options and Stock Appreciation Rights are exercisable during a reasonable period of time
immediately prior to the scheduled consummation of the event or such other reasonable period as determined by the Committee (contingent upon the consummation of the event), and at the end of such period, such Stock Options and Stock Appreciation
Rights shall terminate to the extent not so exercised within the relevant period; and (ii) cancellation of all or any portion of outstanding Awards for fair value (in the form of cash, Shares, other property or any combination thereof) as
determined in the sole discretion of the Committee; provided, that, in the case of Stock Options and Stock Appreciation Rights, the fair value may equal the excess, if any, of the value of the consideration to be paid in the Change in
Control transaction to holders of shares of Common Stock (or, if no such consideration is paid, Fair Market Value of the shares of Common Stock) over the aggregate exercise or base price, as applicable, with respect to such Awards or portion thereof
being canceled, or if no such excess, zero. 
 12.2 Definition of Change in Control. Unless otherwise defined in an
Award Agreement, “Change in Control” shall mean the occurrence of one of the following events: 
 (a) Any
Person, becomes the Beneficial Owner, directly or indirectly, of more than fifty percent (50%) of the combined voting power, excluding any Person who holds fifty percent (50%) or more of the voting power on the Effective Date of the Plan
(the “Initial Owners”), of the then outstanding voting securities of the Company entitled to vote generally in the election of its directors (the “Outstanding Company Voting Securities”) including by way of merger,
consolidation or otherwise; provided, however, that for purposes of this definition, the following acquisitions shall not constitute a Change in Control: (i) any acquisition of voting securities of the Company directly from the
Company, including without limitation, a public offering of securities; (ii) any acquisition by the Company or any of its Subsidiaries of Outstanding Company Voting Securities, including an acquisition by any employee benefit plan or related
trust sponsored or maintained by the Company or any of its Subsidiaries; or (iii) any acquisition after which the Initial Owners and their affiliates remain the Beneficial Owners of more Outstanding Voting Securities than any other Person.

 (b) Consummation of a reorganization, merger, or consolidation to which the Company is a party or a sale or other disposition of all
or substantially all of the assets of the Company (a “Business Combination”), unless, following such Business Combination: (i) any individuals and entities that were the Beneficial Owners of Outstanding Company Voting
Securities immediately prior to such Business Combination are the Beneficial Owners, directly or indirectly, of more than fifty percent (50%) of the combined voting power of the outstanding voting securities entitled to vote generally in the
election of directors (or election of members of a comparable governing body) of the entity resulting from the Business Combination (including, 

  
 16 

 
without limitation, an entity which as a result of such transaction owns all or substantially all of the Company or all or substantially all of the Company’s assets either directly or
through one or more Subsidiaries) (the “Successor Entity”) in substantially the same proportions as their ownership immediately prior to such Business Combination; (ii) no Person (excluding any Successor Entity or any employee
benefit plan or related trust of the Company, such Successor Entity, or any of their Subsidiaries) is the Beneficial Owner, directly or indirectly, of more than fifty percent (50%) of the combined voting power of the then outstanding voting
securities entitled to vote generally in the election of directors (or comparable governing body) of the Successor Entity, except to the extent that such ownership existed prior to the Business Combination; and (iii) at least a majority of the
members of the board of directors (or comparable governing body) of the Successor Entity were Incumbent Directors (including persons deemed to be Incumbent Directors) at the time of the execution of the initial agreement or of the action of the
Board providing for such Business Combination. 
 Notwithstanding the foregoing, to the extent necessary to comply with Section 409A of the Code with
respect to the payment of “nonqualified deferred compensation,” “Change in Control” shall be limited to a “change in control event” as defined under Section 409A of the Code. For the avoidance of doubt, neither a
public offering nor any changes to the size or members of the Board in connection with or as a result of a Public Offering shall constitute or be deemed to result in a Change in Control. 

13. Forfeiture Events. 

13.1 General. The Committee may specify in an Award Agreement at the time of the Award that the Participant’s rights,
payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an
Award. Such events shall include, but shall not be limited to, termination of Service for Cause, violation of material Company policies, breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant or
other similar conduct by the Participant that is detrimental to the business or reputation of the Company.  
 13.2 Termination for
Cause.  
 (a) Treatment of Awards. Unless otherwise provided by the Committee and set forth in an Award Agreement,
if (i) a Participant’s Service with the Company or any Subsidiary shall be terminated for Cause or (ii) within one (1) year following termination of Service for any other reason, the Committee determines in its discretion that,
after termination, the Participant breached any of the material terms contained in any non-competition agreement, confidentiality agreement or similar restrictive covenant agreement to which such Participant is a party, such Participant’s
rights, payments and benefits with respect to an Award shall be subject to cancellation, forfeiture and/or recoupment, as provided in Section 13.3 below. The Company shall have the power to determine whether the Participant has been terminated
for Cause, the date upon which such termination for Cause occurs and whether the Participant engaged in conduct that violated any continuing obligation or duty of the Participant in respect of the Company or any Subsidiary. Any such determination
shall be final, conclusive and binding upon all Persons. In addition, if the Company shall reasonably determine that a Participant has  

  
 17 

 
committed or may have committed any act which could constitute the basis for a termination of such Participant’s Service for Cause or violates any continuing obligation or duty of the
Participant in respect of the Company or any Subsidiary, the Company may suspend the Participant’s rights to exercise any Stock Option or Stock Appreciation Right, receive any payment or vest in any right with respect to any Award pending a
determination by the Company of whether an act or omission could constitute the basis for a termination for Cause as provided in this Section 13.2. 

(b) Definition of Cause. Unless otherwise defined in an Award Agreement, “Cause” shall mean: 

(i) the Participant has committed a deliberate and premeditated act against the interests of the Company including, without limitation: an act
of fraud, embezzlement, misappropriation or breach of fiduciary duty against the Company, including, but not limited to, the offer, payment, solicitation or acceptance of any unlawful bribe or kickback with respect to the Company’s business; or

 (ii) the Participant has been convicted by a court of competent jurisdiction of, or pleaded guilty or nolo contendere to, any felony or
any crime involving moral turpitude; or 
 (iii) the Participant has failed to perform or neglected the material duties incident to his
employment or other engagement with the Company on a regular basis, and such refusal or failure shall have continued for a period of twenty (20) days after written notice to the Participant specifying such refusal or failure in reasonable
detail; or 
 (iv) the Participant has been chronically absent from work (excluding vacations, illnesses, Disability or leaves of absence
approved by the Company); or 
 (v) the Participant has refused, after explicit written notice, to obey any lawful resolution of or
direction by the Board which is consistent with the duties incident to his employment or other engagement with the Company and such refusal continues for more than twenty (20) days after written notice is given to the Participant specifying
such refusal in reasonable detail; or 
 (vi) the Participant has breached any of the material terms contained in any employment agreement,
non-competition agreement, confidentiality agreement or similar type of agreement to which such Participant is a party; or 
 (vii) the
Participant has engaged in (x) the unlawful use (including being under the influence) or possession of illegal drugs on the Company’s premises or (y) habitual drunkenness on the Company’s premises. 

Any voluntary termination of employment or other engagement by the Participant in anticipation of an involuntary termination of the
Participant’s Service for Cause shall be deemed to be a termination for “Cause.” Notwithstanding the foregoing, in the event that a Participant is party to an employment, severance or similar agreement with the Company or any of its
affiliates and such agreement contains a definition of “Cause,” the definition of “Cause” set forth above shall be deemed replaced and superseded, with respect to such Participant, by the definition of “Cause” used in
such employment, severance or similar agreement. 

  
 18 

 13.3 Right of Recapture. 

(a) General. If at any time within one (1) year (or such longer time specified in an Award Agreement or other agreement with
a Participant) after the date on which a Participant exercises a Stock Option or Stock Appreciation Right or on which a Stock Award, Restricted Stock Award or Restricted Stock Unit vests or becomes payable or on which a Cash Performance Award is
paid to a Participant, or on which income otherwise is realized by a Participant in connection with an Award, (i) a Participant’s Service is terminated for Cause or (ii) after a Participant’s Service otherwise terminates for any
other reason, the Committee determines in its discretion that, after termination, the Participant breached any of the material terms contained in any non-competition agreement, confidentiality agreement or similar restrictive covenant agreement to
which such Participant is a party, then any gain realized by the Participant from the exercise, vesting, payment or other realization of income by the Participant in connection with an Award, shall be paid by the Participant to the Company upon
notice from the Company, subject to applicable state law. Such gain shall be determined as of the date or dates on which the gain is realized by the Participant, without regard to any subsequent change in the Fair Market Value of a share of Common
Stock. To the extent not otherwise prohibited by law, the Company shall have the right to offset such gain against any amounts otherwise owed to the Participant by the Company (whether as wages, vacation pay or pursuant to any benefit plan or other
compensatory arrangement). 
 (b) Accounting Restatement. If a Participant receives compensation pursuant to an Award
under the Plan (whether a Stock Option, Cash Performance Award or otherwise) based on financial statements that are subsequently required to be restated in a way that would decrease the value of such compensation, the Participant will, to the extent
not otherwise prohibited by law, upon the written request of the Company, forfeit and repay to the Company the difference between what the Participant received and what the Participant should have received based on the accounting restatement, in
accordance with (i) the Company’s compensation recovery, “clawback” or similar policy, as may be in effect from time to time or (ii) any compensation recovery, “clawback” or similar policy made applicable by law
including the provisions of Section 945 of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules, regulations and requirements adopted thereunder by the Securities and Exchange Commission and/or any national securities
exchange on which the Company’s equity securities may be listed (the “Policy”). By accepting an Award hereunder, the Participant acknowledges and agrees that the Policy shall apply to such Award, and all incentive-based
compensation payable pursuant to such Award shall be subject to forfeiture and repayment pursuant to the terms of the Policy. 
 14.
Transfer, Leave of Absence, Etc. For purposes of the Plan, except as otherwise determined by the Committee, the following events shall not be deemed a termination of employment: (a) a transfer to the employment of the Company from a
Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another; or (b) an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the employee’s right to
re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in writing. 

  
 19 

	15.	General Provisions. 

 15.1 Status of Plan. The Committee may authorize the
creation of trusts or other arrangements to meet the Company’s obligations to deliver stock or make payments with respect to Awards.  

15.2 Award Agreement. To the extent deemed necessary by the Committee, an Award under the Plan shall be evidenced by an Award
Agreement in a written or electronic form approved by the Committee setting forth the number of shares of Common Stock or Restricted Stock Units subject to the Award, the exercise price, base price or purchase price of the Award, the time or times
at which an Award will become vested, exercisable or payable and the term of the Award. The Award Agreement also may set forth the effect on an Award of a Change in Control or a termination of Service under certain circumstances. The Award Agreement
shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions of the Plan, and also may set forth other terms and conditions applicable to the Award as determined by the Committee consistent with the
limitations of the Plan. The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such conditions, as are specified in the Plan as being applicable to such type of
Award (or to all Awards) or as are expressly set forth in the Award Agreement. The Committee need not require the execution of an Award Agreement by a Participant, in which case, acceptance of the Award by the Participant shall constitute agreement
by the Participant to the terms, conditions, restrictions and limitations set forth in the Plan and the Award Agreement as well as the administrative guidelines of the Company in effect from time to time. In the event of any conflict between the
provisions of the Plan and any Award Agreement, the provisions of the Plan shall prevail. 
 15.3 No Assignment or Transfer;
Beneficiaries. Except as provided in Section 6.6 hereof or as otherwise determined by the Committee, Awards under the Plan shall not be assignable or transferable by the Participant, and shall not be subject in any manner to assignment,
alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, in the event of the death of a Participant, except as otherwise provided by the Committee in an Award Agreement, an outstanding Award may be exercised by or shall become
payable to the Participant’s beneficiary as designated by the Participant in the manner prescribed by the Committee or, in the absence of an authorized beneficiary designation, by a legatee or legatees of such Award under the participant’s
last will or by such Participant’s executors, personal representatives or distributees of such Award in accordance with the Participant’s will or the laws of descent and distribution. The Committee may provide in the terms of an Award
Agreement or in any other manner prescribed by the Committee that the Participant shall have the right to designate a beneficiary or beneficiaries who shall be entitled to any rights, payments or other benefits specified under an Award following the
Participant’s death. 
 15.4 Deferrals of Payment. The Committee may in its discretion permit a Participant to
defer the receipt of payment of cash or delivery of shares of Common Stock that would otherwise be due to the Participant by virtue of the exercise of a right or the satisfaction of  

  
 20 

 
vesting or other conditions with respect to an Award; provided, however, that such discretion shall not apply in the case of a Stock Option or Stock Appreciation Right. If any
such deferral is to be permitted by the Committee, the Committee shall establish rules and procedures relating to such deferral in a manner intended to comply with the requirements of Section 409A of the Code, including, without limitation, the
time when an election to defer may be made, the time period of the deferral and the events that would result in payment of the deferred amount, the interest or other earnings attributable to the deferral and the method of funding, if any,
attributable to the deferred amount. 
 15.5 No Right to Employment or Continued Service. Nothing in the Plan, in the
grant of any Award or in any Award Agreement shall confer upon any Eligible Person or any Participant any right to continue in the Service of the Company or any of its Subsidiaries or interfere in any way with the right of the Company or any of its
Subsidiaries to terminate the employment or other service relationship of an Eligible Person or a Participant for any reason at any time. 

15.6 Stock Certificates. The Committee may determine in its discretion the manner of delivery of Common Stock to be issued under
the Plan, which may be by delivery of stock certificates, electronic account entry into new or existing accounts or any other means as the Committee, in its discretion, deems appropriate. The Committee may require that the stock certificates (if
any) be held in escrow by the Company for any shares of Common Stock or cause the shares to be legended in order to comply with the securities laws or other applicable restrictions or should the shares of Common Stock be represented by book or
electronic account entry rather than a certificate, the Committee may take such steps to restrict transfer of the shares of Common Stock as the Committee considers necessary or advisable. 

15.7 Trading Policy Restrictions. Option exercises and other Awards under the Plan shall be subject to such Company’s
insider-trading-policy-related restrictions, terms and conditions to the extent established by the Committee, or in accordance with policies set by the Committee, from time to time.  

15.8 Section 409A Compliance. To the extent applicable, it is intended that the Plan and all Awards hereunder comply with,
or be exempt from, the requirements of Section 409A of the Code and the Treasury Regulations and other guidance issued thereunder, and that the Plan and all Award Agreements shall be interpreted and applied by the Committee in a manner
consistent with this intent in order to avoid the imposition of any additional tax under Section 409A of the Code. In the event that any (i) provision of the Plan or an Award Agreement, (ii) Award, payment, transaction or
(iii) other action or arrangement contemplated by the provisions of the Plan is determined by the Committee to not comply with the applicable requirements of Section 409A of the Code and the Treasury Regulations and other guidance issued
thereunder, the Committee shall have the authority to take such actions and to make such changes to the Plan or an Award Agreement as the Committee deems necessary to comply with such requirements; provided, that no such action shall
adversely affect any outstanding Award without the consent of the affected Participant. No payment that constitutes deferred compensation under Section 409A of the Code that would otherwise be made under the Plan or an Award Agreement upon a
termination of Service will be made or provided unless and until such termination is also a “separation from service,” as determined in accordance with  

  
 21 

 
Section 409A of the Code. Notwithstanding the foregoing or anything elsewhere in the Plan or an Award Agreement to the contrary, if a Participant is a “specified employee” as
defined in Section 409A of the Code at the time of termination of Service with respect to an Award, then solely to the extent necessary to avoid the imposition of any additional tax under Section 409A of the Code, the commencement of any
payments or benefits under the Award shall be deferred until the date that is six (6) months plus one (1) day following the date of the Participant’s termination of Service or, if earlier, the Participant’s death (or such other
period as required to comply with Section 409A). In no event whatsoever shall the Company be liable for any additional tax, interest or penalties that may be imposed on a Participant by Section 409A of the Code or any damages for failing
to comply with Section 409A of the Code. 
 15.9 Securities Law Compliance.  

(a) General. No shares of Common Stock will be issued or transferred pursuant to an Award unless and until all then applicable
requirements imposed by Federal and state securities and other laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges upon which the shares of Common Stock may be listed, have been fully met. As a
condition precedent to the issuance of shares pursuant to the grant or exercise of an Award, the Company may require the Participant to take any reasonable action to meet such requirements. The Committee may impose such conditions on any shares of
Common Stock issuable under the Plan as it may deem advisable, including, without limitation, restrictions under the Securities Act of 1933, as amended, under the requirements of any exchange upon which such shares of the same class are then listed,
and under any blue sky or other securities laws applicable to such shares. The Committee may also require the Participant to represent and warrant at the time of issuance or transfer that the shares of Common Stock are being acquired only for
investment purposes and without any current intention to sell or distribute such shares. 
 (b) Compliance with Rule
701. For Awards granted prior to a Public Offering and the filling of an effective registration statement on Form S-8, the Plan is intended to be a written compensatory benefit plan within the meaning of Rule 701 promulgated under the Securities
Act and, therefore, such Awards are subject to the restrictions set forth in Rule 701, and are “restricted securities,” as such term is defined in Rule 144 promulgated under the Securities Act, and any resale of the Shares underlying such
Awards must be in compliance with the registration requirements of the Securities Act or an exemption therefrom. Awards issued pursuant to the Plan prior to a Public Offering and the filling of an effective registration statement on Form S-8 shall
in no event exceed the limitations set forth in Rule 701(d), as applicable from time to time. 
 15.10 Substitute Awards in
Corporate Transactions. Nothing contained in the Plan shall be construed to limit the right of the Committee to grant Awards under the Plan in connection with the acquisition, whether by purchase, merger, consolidation or other corporate
transaction, of the business or assets of any corporation or other entity. Without limiting the foregoing, the Committee may grant Awards under the Plan to an employee or director of another corporation who becomes an Eligible Person by reason of
any such corporate transaction in substitution for awards previously granted by such corporation or entity to such person. The terms and conditions of the substitute Awards may vary from the terms and conditions that would otherwise be required by
the Plan solely to the extent the Committee deems necessary for such purpose. Any such substitute awards shall not reduce the Share Reserve. 

  
 22 

 15.11 Tax Withholding. The Participant shall be responsible for payment of any
taxes or similar charges required by law to be paid or withheld from an Award or an amount paid in satisfaction of an Award. Any required withholdings shall be paid by the Participant on or prior to the payment or other event that results in taxable
income in respect of an Award. The Award Agreement may specify the manner in which the withholding obligation shall be satisfied with respect to the particular type of Award, which may include permitting the Participant to elect to satisfy the
withholding obligation by tendering shares of Common Stock to the Company or having the Company withhold a number of shares of Common Stock having a value equal to the minimum statutory tax or similar charge required to be paid or withheld.

 15.12 Unfunded Plan. The adoption of the Plan and any reservation of shares of Stock or cash amounts by the Company to
discharge its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any rights of a Participant under the Plan shall be those of a general unsecured
creditor of the Company, and neither a Participant nor the Participant’s permitted transferees or estate shall have any other interest in any assets of the Company by virtue of the Plan. Notwithstanding the foregoing, the Company shall have the
right to implement or set aside funds in a grantor trust, subject to the claims of the Company’s creditors or otherwise, to discharge its obligations under the Plan. 

15.13 Other Compensation and Benefit Plans. The adoption of the Plan shall not affect any other share incentive or other
compensation plans in effect for the Company or any Subsidiary, nor shall the Plan preclude the Company from establishing any other forms of share incentive or other compensation or benefit program for employees of the Company or any Subsidiary. The
amount of any compensation deemed to be received by a Participant pursuant to an Award shall not constitute includable compensation for purposes of determining the amount of benefits to which a Participant is entitled under any other compensation or
benefit plan or program of the Company or a Subsidiary, including, without limitation, under any pension or severance benefits plan, except to the extent specifically provided by the terms of any such plan. 

15.14 Plan Binding on Transferees. The Plan shall be binding upon the Company, its transferees and assigns, and the Participant,
the Participant’s executor, administrator and permitted transferees and beneficiaries. 
 15.15 Severability. If
any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their
terms, and all provisions shall remain enforceable in any other jurisdiction. 
 15.16 Governing Law. The Plan and all
rights hereunder shall be subject to and interpreted in accordance with the laws of the State of Delaware, without reference to the principles of conflicts of laws, and to applicable Federal securities laws. 

  
 23 

 15.17 No Fractional Shares. Unless otherwise determined by the Committee, no
fractional shares of Common Stock shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash, other securities or other property shall be paid or transferred in lieu of any fractional shares of
Common Stock or whether such fractional shares or any rights thereto shall be canceled, terminated or otherwise eliminated. 
 15.18
No Guarantees Regarding Tax Treatment. Neither the Company nor the Committee make any guarantees to any person regarding the tax treatment of Awards or payments made under the Plan. Neither the Company nor the Committee has any obligation to
take any action to prevent the assessment of any tax on any person with respect to any Award under Section 409A of the Code, Section 4999 of the Code or otherwise and neither the Company nor the Committee shall have any liability to a
person with respect thereto. 
 15.19 Data Protection. By participating in the Plan, each Participant consents to the
collection, processing, transmission and storage by the Company, its Subsidiaries and any third party administrators of any data of a professional or personal nature for the purposes of administering the Plan. 

15.20 Awards to Non-U.S. Participants. To comply with the laws in countries other than the United States in which the Company or
any of its Subsidiaries or affiliates operates or has employees, Non-Employee Directors or consultants, the Committee, in its sole discretion, shall have the power and authority to (i) modify the terms and conditions of any Award granted to
Participants outside the United States to comply with applicable foreign laws, (ii) take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local government regulatory
exemptions or approvals and (iii) establish subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any subplans and modifications to Plan terms and procedures
established under this Section 15.20 by the Committee shall be attached to this Plan document as appendices. 
 16. Term;
Amendment and Termination; Stockholder Approval. 
 16.1 Term. The Plan shall be effective as of the date of adoption by the
Board, which date is set forth below (the “Effective Date”). Subject to Section 16.2 hereof, the Plan shall terminate on the tenth anniversary of the Effective Date. 

16.2 Amendment and Termination. The Board may from time to time and in any respect, amend, modify, suspend or terminate the Plan;
provided, that, no amendment, modification, suspension or termination of the Plan shall adversely affect any Award theretofore granted without the consent of the Participant or the permitted transferee of the Award. The Board may seek the approval
of any amendment, modification, suspension or termination by the Company’s stockholders to the extent it deems necessary or advisable in its discretion for purposes of compliance with Section 162(m) or Section 422 of the Code, the
listing requirements of the New York Stock Exchange or other exchange or securities market or for any other purpose. 

  
 24 

 16.3 Stockholder Approval. The Plan will be submitted for approval by the stockholders of
the Company within twelve months of the Effective Date. Any Awards granted under the Plan prior to such approval of the stockholders shall be effective as of the applicable date of grant, but no such Award may be exercised or settled and no
restrictions relating to any Award may lapse prior to such stockholder approval, and if the stockholders fail to approve the Plan as specified hereunder, the Plan and any Awards issued thereunder shall be terminated and cancelled without
consideration. 
 16.4 Re-Approval of Performance Criteria. At the discretion of the Board, for purposes of compliance with
Section 162(m) of the Code, the Company may seek approval by the Company’s stockholders of the Performance Criteria (or other designated performance goals) and such other provisions as determined by the Board no later than the Annual
General Meeting of Stockholders in the third year following the year in which a Public Offering first occurs. 

*        *        *       
 * 
 This Plan was duly adopted and approved by the Board of Directors of the Company by resolution at a meeting held on May 29,
2015. 

  
 25 

 APPENDIX I 

CANADIAN RESIDENT EMPLOYEES 
  

	 	1.	This Appendix I shall apply to all Participants who are Canadian Resident Employees (as defined below). In the event that a Participant becomes a Canadian Resident Employee subsequent to the grant of an Award under the
Plan, then, pursuant to Section 15.20 of the Plan, such Award shall immediately and automatically be amended in a manner consistent with this Schedule unless otherwise determined by the Committee. 

 

	 	2.	In this Schedule, the following terms shall have the meanings set forth below: 

 ITA
means the Income Tax Act (Canada) as it may be amended from time to time and all regulations, interpretations and administrative guidance issued thereunder; 

Canadian Resident Employee means an employee of the Company or any of its Subsidiaries who is a resident in Canada for purposes of the
ITA and any applicable income tax treaty or convention;  
 NI 45-102 means National Instrument 45-102—Resale of
Securities; and 
 NI 45-106 means National Instrument 45-106—Prospectus Exemptions. 

 

	 	3.	Section 2 shall be amended to replace the last sentence in the definition “Fair Market Value” in its entirety with the following: 

“If the Common Stock is not listed on any such exchange, “Fair Market Value” shall be such value as determined in good faith by
the Board in its discretion.” 
  

	 	4.	Section 2 shall be amended to include at the end of the definition of “Public Offering” the following: 

“or a prospectus pursuant to applicable Canadian securities laws.” 

 

	 	5.	Section 6.1 shall be deleted in its entirety and replaced with the following: 

“Grant of Stock Option. A Stock Option may be granted to any Eligible Person selected by the Committee. All Stock Options
granted under the Plan are intended to comply with Section 7 of the ITA.” 
  

	 	6.	Section 6.5 shall be deleted in its entirety and replaced with the following: 

“Stock Option Exercise; Tax Withholding. Subject to such terms and conditions as specified in an Award Agreement, a Stock
Option may be exercised in whole or in part at any time during the term thereof by notice in the form required by the Company, together with payment of the aggregate exercise price and applicable withholding tax. Payment of the exercise price may be
made: (i) in cash or by cash equivalent acceptable by the Committee or (ii) to the extent permitted by the Committee in its sole discretion and set  

  
 26 

 
forth in the Award Agreement or otherwise (including by a policy or resolution of the Committee), (A) through an open-market, broker-assisted sales transaction pursuant to which the
Company is promptly delivered the amount of proceeds necessary to satisfy the exercise price or (B) by such other method as may be approved by the Committee and set forth in the Award Agreement. In addition to and at the time of payment of the
exercise price as may be approved by the Committee and set forth in the Award Agreement.” 
  

	 	7.	Section 6.6 shall be deleted in its entirety and replaced with the following: 

“Limited Transferability of Nonqualified Stock Options. All Stock Options shall be non-transferable except (i) upon the
Participant’s death, in accordance with Section 15.3 hereof or (ii) pursuant to an exemption from the prospectus requirements under NI 45-106 and NI 45-102, in each case as may be approved by the Committee in its discretion at the
time of the proposed transfer. The transfer of a Stock Option may be subject to such terms and conditions as the Committee may in its discretion impose from time to time.” 

 

	 	8.	Section 6.7 shall be deleted in its entirety. 

  

	 	9.	Section 6.9 shall be deleted in its entirety. 

  

	 	10.	Section 7.1 shall be amended to delete the last sentence in its entirety. 

  

	 	11.	Section 7.5 shall be deleted in its entirety. 

  

	 	12.	Section 8.2 shall be amended to delete the words “designed to meet the requirements for exemption under Section 162(m) of the Code”. 

 

	 	13.	Section 8.5 shall be deleted in its entirety. 

  

	 	14.	Section 9.1 shall be amended to delete the words “designed to meet the requirements for exemption under Section 162(m) of the Code, or otherwise”. 

 

	 	15.	Section 9.2 shall be deleted in its entirety. 

  

	 	16.	Section 10.1 shall be amended to delete the words the following: 

 “With respect to
Cash Performance Awards and other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code, before the 90th day of the applicable performance
period (or, if the performance period is less than one year, no later than the number of days which is equal to 25% of such performance period), the Committee will determine the duration of the performance period, the Performance Criteria, the
applicable Performance Goals relating to the performance Criteria, and the amount and terms of payment and/or vesting upon achievement of the Performance Goals.” 
  

	 	17.	Section 10.2 shall be deleted in its entirety. 

  
 27 

	 	18.	Section 10.3 shall be amended to delete the words “and other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code”. 

 

	 	19.	Section 10.5 shall be deleted in its entirety. 

  

	 	20.	Section 10.7 shall be amended to delete the words “or other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code”. 

 

	 	21.	Section 10.8 shall be amended to delete the words “or other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code”. 

 

	 	22.	Section 10.9 shall be amended to delete the words “or other Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code”. 

 

	 	23.	Section 13.2(b)(ii) shall be amended to replace the word “felony” with the words “indictable offence”. 

  

	 	24.	Section 13.3(a) shall be amended to replace the words “applicable state law” with the words “applicable law”. 

 

	 	25.	Section 13.3(b) shall be amended to replace the words “national securities exchange” with the words “securities exchange”. 

 

	 	26.	Section 15.3 shall be deleted in its entirety and replaced with the following: 

“No Assignment or Transfer; Beneficiaries. Except as provided in Section 6.6 hereof or as otherwise determined by the
Committee, Awards under the Plan shall not be assignable or transferable by the Participant, and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, in the event of the death of
a Participant, except as otherwise provided by the Committee in an Award Agreement, subject to applicable Canadian securities laws, an outstanding Award may be exercised by or shall become payable to the Participant’s beneficiary as designated
by the Participant in the manner prescribed by the Committee or, in the absence of an authorized beneficiary designation, by a legatee or legatees of such Award under the participant’s last will or by such Participant’s executors, personal
representatives or distributees of such Award in accordance with the Participant’s will or the laws of descent and distribution. The Committee may provide in the terms of an Award Agreement or in any other manner prescribed by the Committee
that the Participant shall have the right to designate a beneficiary or beneficiaries who shall be entitled to any rights, payments or other benefits specified under an Award following the Participant’s death.” 

 

	 	27.	Section 15.4 shall be amended to delete the last sentence in its entirety. 

  

	 	28.	Section 15.8 shall be deleted in its entirety. 

  

	 	29.	Section 15.9(a) shall be amended to replace the last sentence in its entirety with the following: 

  
 28 

 “The Committee may also require the Participant to represent and warrant at the time of
issuance or transfer that his or her participation in the distribution is voluntary and the securities being acquired for investment purposes and without any current intention to sell or distribute such securities.” 

 

	 	30.	Section 15.9(b) shall be deleted in its entirety and replaced with the following: 

“Compliance with Securities Laws. For Awards granted prior to a Public Offering, the Plan is intended to be a written
compensatory benefit plan within the meaning of Rule 701 promulgated under the Securities Act and, therefore, such Awards are subject to the restrictions set forth in Rule 701, and are “restricted securities,” as such term is defined in
Rule 144 promulgated under the Securities Act, and any resale of the Shares underlying such Awards must be in accordance with NI 45-102 and in compliance with the registration requirements of the Securities Act or an exemption therefrom. Awards
issued pursuant to the Plan prior to a Public Offering and the filling of an effective registration statement on Form S-8 shall in no event exceed the limitations set forth in Rule 701(d), as applicable from time to time.” 

 

	 	31.	Section 15.11 shall be amended to delete the following words: 

 “, which may include
permitting the Participant to elect to satisfy the withholding obligation by tendering shares of Common Stock to the Company or having the Company withhold a number of shares of Common Stock having a value equal to the minimum statutory tax or
similar charge required to be paid or withheld.” 
  

	 	32.	Section 15.18 shall be amended to delete the following the words: 

 “under
Section 409A of the Code, Section 4999 of the Code or otherwise”. 

  
 29

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]